寿胎丸加味方治疗肾虚型先兆流产、习惯性流产的临床研究
|
摘要
目的：系统回顾祖国医学和西方医学对先兆流产和习惯性流产的认识和治疗,全面观察导师临床保胎经验总结方-寿胎丸加味方加减治疗肾虚型胎漏、胎动不安、滑胎的临床疗效,以及治疗前后内分泌激素免疫抗体、免疫性NK细胞活性及Th1/Th2细胞因子的变化,以期从内分泌-免疫学角度探讨其保胎的作用机理,为丰富中医药理论、探讨中医药保胎机理和临床研究有效的中药复方制剂做基础性临床研究。同时也是为导师前期动物实验基础上临床研究补充。
方法：
第一部分临床疗效观察
随机选取在湖南中医药大学第二附属医院和湖南省妇幼保健院妇科门诊及住院早期先兆流产、习惯性流产要求保胎中医辨证为肾虚型或肾脾虚弱型的患者和流产不可避免或流产不全要求清宫的患者,妇幼保健科接待的正常孕妇,总共160例,分成4组：寿胎丸加味方治疗组50例,保胎灵治疗对照组50例,流产对照组30例,正常妊娠而未服用保胎药物对照组30例。4组病人同时都口服维生素E：100mg, bid×60天和叶酸：0.4mg, Qd×90天。观察治疗前后的疗效和症候的改变及一般性安全性观察。
第二部分寿胎丸加味方临床治疗内分泌—免疫学调节机理研究
放射免疫法(RIA)检测寿胎丸加味方治疗组例和保胎灵治疗对照组治疗前后血清HCG、P、β-EP的变化并较正常妊娠组比较。放射免疫法(RIA)检测外周血EMAB(抗子宫内膜抗体)、AsAb(抗精子抗体)、ACA(抗心磷脂抗体)的变化。采用ELSIA方法检测外周血NK细胞活性及血TNF-α、IFN-γ、IL-4、IL-10治疗前后的变化。
第三部分保胎治疗后对子代生长发育的初步观察
通过电话、网络或上门随访了部分经保胎治疗后新生儿出生时一般情况包括小儿年龄、性别、分娩时孕周、分娩方式、出生时Apgar评分、喂养方式、食量、情绪、有无先天性疾病、有无新生儿窒息史、颅内出血及其他新生儿期疾病等。出生时的身长、体重、头围、胸围等数据,婴幼儿的营养状况、骨骼发育、脑与颅骨发育及胸廓、胸背肌肉、皮下脂肪与肺的发育等情况。
第四部分文献研究
采用计算机网络技术及其文献检索、流行病学回顾性等研究方法对祖国医学,现代医学以及中西医结合医学关于胎漏、胎动不安及滑胎的病名、病因病机、治疗方法、临床方药研究及当前的临床研究进展进行综述。表明中医药保胎的治疗有良好疗效和优势,值得临床研究和推广。
结果：
第一部分临床疗效观察
50例服用寿胎丸加味方加减治疗后患者经综合疗效判定标准判断,治愈18例,显效17例,有效8例,无效7例,总有效率86%；50例服用保胎灵治疗后患者经综合疗效判定标准判断,治愈12例,显效16例,有效12例,无效10例,总有效率80%；两组有效率均较高,但采用寿胎丸加味方加减治疗后的总有效率(86%)要高于保胎灵对照治疗组(80%),但两组比较,P>0.05,差异无显著意义。而寿胎丸加味方治疗组在改善阴道流血、神疲乏力、夜尿频多方面明显优于保胎灵治疗对照组,且有显著性差异(P<0.05)。两组治疗前后外周血RBC、WBC、HGB, AST、ALT、GGT, CREA、BUN均在正常范围内,前后比较差异统计意义(P>0.05)。
第二部分寿胎丸加味方临床治疗内分泌—免疫学调节机理研究
检测用药前四组血HCG、P的值,记录用药后两用药组血HCG、P的变化,并同时检测同期正常妊娠组的HCG、P值进行比较,流产对照组相对于其他3组,血HCG、P值明显偏低,与其他3组比较,差异具有显著意义(P<0.01),其他3组比较,发生流产症状治疗两组血HCG、P要低于正常妊娠组,但两用药治疗组比较,差异无显著意义(P>0.05),具有可比性。两用药组用药治疗后血HCG、P上升,前后比较差异具有显著意义(P<0.05)；两组治疗后虽较正常妊娠组低,但差异无显著意义(P>0.05)。两用药组治疗前后上升幅度跟正常妊娠组相当,差异无显著意义(P>0.05)。检测用药前四组外周血的值,记录用药后两用药组血β-EP的变化,并同时检测同期正常妊娠组的β-EP值进行比较,流产对照组相对于其他3组,血β-EP值明显增高,与其他3组比较,差异具有显著意义(P<0.01)；其他3组比较,发生流产治疗两组血β-EP仍要高于正常妊娠组,但低于流产组,用药前两治疗组比较,差异无显著意义(P>0.05),具有可比性。两用药组用药治疗后血β-EP降低,前后比较差异具有显著意义(P<0.01)。两组用药治疗前后血AsAb的阳性率比较差异具有统计意义(P<0.05),血EmAb的阳性率比较差异无统计学意义(P>0.05),而血ACA经寿胎丸加味方治疗后阳性率下降,而保胎灵治疗后无改变。流产对照组的NK细胞活性较正常妊娠对照组明显升高(P<0.01),较寿胎丸加味方治疗组和保胎灵治疗组也显著升高(P<0.01),而寿胎丸加味方治疗组和保胎灵治疗组治疗前较正常妊娠对照组也显著升高(P<0.01),两治疗组治疗前后比较NK细胞活性降低,差异具有统计学意义(P<0.01)。已发生流产的流产对照组TNF-α、IFN-γ含量较正常妊娠组明显升高(P<0.01),较两治疗组治疗前比较也显著升高(P<0.01),两治疗组治疗后较妊娠正常组比较也高,差异具有统计意义(P<0.01)。相反,已发生流产的流产对照组IL-4、IL-10含量较正常妊娠组明显偏低(P<0.01),较两治疗组治疗前比较也显著偏低(P<0.01)。
第三部分保胎治疗后对子代生长发育的初步观察
随访已生育46例产妇中,新生儿年龄最大1周岁,最小刚出生1周；其中未有早产儿,足月小样儿,畸形儿等,且都未发生新生儿窒息史、颅内出血等其他情况,母儿均正常。出生时的体重、身长、头围、胸围、臀围跟未采取保胎治疗的新生儿比较,差异无统计学意义(P>0.05)。
第四部分文献研究
通过文献总结和分析,祖国医学对于胎漏、胎动不安及滑胎的认识全面,“肾主生殖”病机主要在肾,滑胎更多责之于肾脾虚弱,寿胎丸临床安胎疗效突出,较西医安胎安全。目前已得到公认。从内分泌免疫方面研究流产和治疗的机理,是目前研究的热点。
结论：
1.寿胎丸加味方和保胎灵均为临床治疗肾虚型胎漏、胎动不安、滑胎的效果肯定有效方药,尤其是在改善临床症状方面寿胎丸加味方加减疗效要优于保胎灵。
2.流产次数越多,再次妊娠流产的可能性更大,保胎治疗的疗效越小,这可能与多次流产损伤子宫内膜有关联,“预培其损”是保胎治疗的关键。
3.血HCG、P检测可作为早孕期判断孕囊、胚胎生长发育和判断预后的参考性指标之一,寿胎丸加味方和保胎灵均具有改善黄体黄体功能,促进血HCG, P的增长有助于妊娠的继续
4.寿胎丸加味方加减和保胎灵均可以降低因应激而升高的β-内啡肽从神经内分泌和免疫因子的调节方面对妊娠的维持产生一定的作用。而寿胎丸加味方在降低内啡肽方面更突出,初步推断中医采用“宁心安神”降低机体的应激使内啡肽的分泌减少而有助于妊娠的继续。
5.寿胎丸加味方和保胎灵均可能降低或消除存在血清自体型抗体或同种异体型抗体而有助于妊娠,而寿胎丸加味方加减更可能有疗效,且中医药治疗较西药安全,无副作用。值得进一步研究。
6.发生流产或出现流产症状时外周血NK细胞活性增强,Th1细胞因子的分泌增加,寿胎丸加味方和保胎灵均可能降低外周血NK细胞的活性和降低Th1细胞因子的分泌,促进Th2型细胞因子的分泌,调节Th1/Th2细胞因子的平衡是以Th2为主导的免疫保护,减轻其对胚胎的细胞毒性和免疫损伤作用而有助于妊娠的继续,而寿胎丸加味方随证加减在此方面可能要优于保胎灵。
7.补肾益气安胎中药用药安全,对母体无毒副作用,对子代出生和生长发育没有影响。但仍需进一步长时间随访观察和子代智力发育情况,也需要对其进行生殖毒性、遗传毒性等方面的进一步研究。
8.通过回顾和总结中医历代文献及现代医学关于流产及治疗的研究进展,祖国医学认为肾脾虚损、气血不足、冲任损伤、胎元不固是主要病机,而肾不固胎,脾失摄养导致胎元不固为发病关键,而现代医学关于复发性习惯性流产多考虑内分泌免疫因素。
Objective:
The system reviews the Chinese tradition medicine and the Western medicine the understanding and the treatment which miscarries to the threatened miscarriage and routine, observes teacher the clinical fetus protection experience to summarize the side-long-lived embryo pill comprehensively to add the taste side addition and subtraction treatment spleen kidney two empty embryos to leak, painful fetal movement, the abortion clinical curative effect, as well as around the treatment the endocrine hormone, the immunity immune body, immunity NK cell activeness and Thl/Th2 cell factor change, discusses its fetus protection by the time from the endocrine-immunology angle the action mechanism, for the rich Chinese medicine theory, the discussion Chinese medicine fetus protection mechanism and the clinical research effective Chinese native medicine compound prescription preparation does the foundational clinical research.Simultaneously also is for teacher in the preliminary animal experimentation foundation the clinical research supplement.
Methods:
The first part Clinical curative effect observation
Stochastic selection in the Hunan Chinese medicine university second affiliated hospital and the Hunan Province women's and children's dispensary gynecology department outpatient service and in hospital early time threatened miscarriage, the routine miscarriage requests the fetus protection Chinese medicine dialectical empty either the spleen kidney two empty patients and miscarries the patient for the kidney who inevitable or the miscarriage not all requests the clear palace, the normal pregnant woman who the mother and child care branch reception embryo works, the altogether 160 examples, divide into 4 groups:The long-lived embryo pill adds the taste side treatment group 50 examples, guarantees the treatment control group 50 examples, miscarries the control group 30 examples, the eukyesia has not taken the fetus protection medicine control group 30 examples.4 group of patients simultaneously all take orally the Vitamin E:100mg, bid×60 day and the folic acid:0.4mg, Qd×90 day.Around observation treatment curative effect and symptom change and general secure observation.
The second part Clinical endocrine internal secretion-immunology research
Emission immunity law (RIA) examines the long-lived embryo pill to add the taste side treatment group example and the fetus protection spirit treatment control group treats blood serum HCG, P,β-EP the change and the eukyesia group comparison.Emission immunity law (RIA) examination circumference blood EMAB (anti-endometrium immune body), AsAb (anti-sperm immune body), ACA (anti-cuorin immune body) change.Uses ELSIA method examination circumference blood NK cell activeness and the blood TNF-α, IFN-γ, IL-4, around the IL-10 treatment change.
Around third part Fetus protection treatment the antithetical couplet generation of growth growth preliminary observation
Through the telephone, the network or visits made a follow-up visit the part after the fetus protection treatment when the newborn birth the ordinary circumstances including when the young child age, the sex, the childbirth is pregnant when the week, the childbirth way, the birth the Apgar grading, feeds the way, the appetite, the mood, whether there is the congenital disease, whether there is the newborn suffocates the history, the skull internal hemorrhage and other newborn time disease and so on.Time the birth height, the body weight, encircle, data and so on chest measurement, babies and infants' nutrition condition, the skeleton growth, the brain and the skull growth and the chest gallery, chest back muscle, hypodermic fat and lung situations and so on growth..
The fourth part Literature research
Uses research techniques and so on computer network technology and literature retrieval, epidemiology review to the motherland medicine, the modern medicine as well as the cooperation of Chinese and Western medicine medicine leaks, about the embryo painful fetal movement and the abortion sickness name, the cause of disease pathogenesis, the method of treatment, clinical Fang Yao studies and the current clinical research progress carries on the summary.Indicated the Chinese medicine fetus protection treats has the good effect and the superiority, is worth the clinical research and the promotion.
Results:
The first part Clinical curative effect observes
50 examples to take the long-lived embryo pill to add the taste side addition and subtraction treatment future trouble after the synthesis curative effect determination standard judgment, cures 18 examples, shows results 17 examples, effective 8 examples, invalid 7 examples, total effectiveness 86%; 50 examples take the fetus protection spirit treatment future trouble after the synthesis curative effect determination standard judgment, cures 12 examples, shows results 16 examples, effective 12 examples, invalid 10 examples, total effectiveness 80%; Two groups of effectiveness are high, after but uses the long-lived embryo pill to add the taste side addition and subtraction treatment total effectiveness (86%) to have to be higher than the fetus protection spirit comparison treatment group (80%), but two groups of differences after Radit analysis, P>0.05, difference not remarkable significance.But the long-lived embryo pill adds the taste side treatment group to improve the vagina to bleed, the god tired strength, a night of frequent micturition many, surpasses the fetus protection spirit treatment control group obviously, also has the significance difference (P>0.05).Around two groups treat circumference blood RBC, WBC, HGB, AST, ALT, GGT, CREA, BUN in the normal range, around the comparison difference statistics significance (P>0.05).
The second part Clinical endocrine internal secretion-immunology
Research examination medication four group of blood HCG, the P value, the recording applies drugs latter two medication group blood HCG, the P change, and simultaneously examines the same time eukyesia group HCG, the P value carries on the comparison, miscarries the control group to be opposite obviously in other 3 groups, blood HCG, the P value somewhat low, compares with other 3 groups, the difference has the remarkable significance (P<0.01), other 3 groups compare, have the miscarriage symptom to treat two group of blood HCG, P must be lower than the eukyesia group, but two medication treatment group compares, the difference not remarkable significance (P>0.05), has the commeasurability.After two medication group medication treatment blood HCG, the P rise, around the comparison difference has the remarkable significance (P<0.01); Although after two groups treat the eukyesia group to be low, but difference not remarkable significance (P>0.05). Around two medication groups treat the rise scope with the eukyesia group quite, difference not remarkable significance (P>0.05).Before the examination medication four group of circumference blood value, the recording applies drugs the latter two medication group bloodβ-EP change, and simultaneously examines the same time eukyesia groupβ-EP the value to carry on the comparison, miscarries the control group to be opposite in other 3 groups, the bloodβ-EP value obvious markup, compares with other 3 groups, the difference has the remarkable significance (P<0.01); Other 3 groups of comparisons, had the miscarriage to treat two groups of blood P-EP still to have to be higher than the eukyesia group, but was lower than the miscarriage group, before the medication two treatment group comparison, the difference not remarkable significance (P>0.05), had the commeasurability. After two medication group medication treatment the blood P-EP reduces, around the comparison difference has the remarkable significance (P<0.01); Two groups'treated the eukyesia group to be still high, but difference not remarkable significance (P>0.05).Around but two group of medication treatments blood AsAb, masculine gender rate comparison difference has the statistical significance (P<0.05) blood ACA to add the taste side treatment after the long-lived embryo pill the masculine gender rate drop, after but the fetus protection spirit treatment does not have changes.The miscarriage control group's NK cell activeness eukyesia control group elevates obviously (P<0,01), the long-lived embryo pill adds the taste side treatment group and the fetus protection spirit treatment group also obviously elevates (P<0.01) around, but the long-lived embryo pill adds the taste side treatment group and the fetus protection spirit treatment group treats the eukyesia control group also obviously to elevate (P<0.01), two treatment groups treats compares the NK cell activeness to reduce, the difference has statistics significance (P<0.01). After two treatment groups treated the eukyesia group to compare still are also high, the difference also had statistics significance (P<0.Ol).Has had the miscarriage miscarriage control group TNF-α, IFN-γthe content eukyesia group elevates obviously (P<0.01) before, two treatment groups treat compare also obviously elevate (P<0.01), after two treatment groups treat compare the eukyesia group to compare also high, the difference has the statistical significance (P<0.01).On the contrary, has had miscarriage miscarriage control group IL-4, the IL-10 content eukyesia group obvious somewhat low (P<0.01) before, two treatment groups treat obviously compare also somewhat low (P<0.01).
The third part Fetus protection treatment the antithetical couplet generation of growth growth preliminary observation
Revisit has given birth in 46 example parturient women, the newborn age is biggest 1 full year old, smallest just was born 1 week; In which has not had the premature infant, the full-term galley proof, abnormal and so on, also all has not had the newborn to suffocate the history, the skull internal hemorrhage and so on other situations, the mother is normal.Time the birth body weight, the height, encircle, the chest measurement, the hips with have not adopted the fetus protection treatment the newborn comparison, the difference non-statistics significance (P>0.05).
The fourth part Literature research
Through the literature summary and the analysis, the motherland medicine leaks, regarding the embryo painful fetal movement and the abortion knows comprehensively, "the kidney host reproduction" the pathogenesis in the kidney, abortion Yu of Pishen more responsibility two empty, the long-lived embryo pill clinical peaceful embryo curative effect is mainly prominent, compares the doctor practicing western medicine peaceful embryo security.At present obtained the recognition. Studies the mechanism from the endocrine-immunity aspect which miscarries and treats, is hot spot which at present studies.
Conclusion:
1. Long-lived embryo pills add the taste side and the fetus protection work leak, for the clinical treatment spleen kidney two empty embryos painful fetal movement, the abortion effect affirmation effective side medicine, in particular adds the taste side addition and subtraction curative effect in the improvement clinical symptom aspect long-lived embryo pill to have to surpass the fetus protection spirit.
2. Miscarriage number of times are more, the pregnancy miscarries once more the possibility is bigger, the fetus protection treatment curative effect is smaller, this possible and miscarries many times damages the endometrium to have the connection, "cultivates it to damage is the fetus protection treatment key in advance".
3. Blood HCG, the P examination may take the early gestation period judgment is pregnant the pouch, the embryo growth grows and judges one of prognosis referential targets, the long-lived embryo pill adds the taste side and the fetus protection works has improves Huang Tihuang the body function, promotion blood HCG, the P growth is helpful in the pregnancy continuation
4. Long-lived embryo pill adds the taste side addition and subtraction and the fetus protection works may reduce theβ-endorphin which elevates because of the stress from the god internal secretion and the immunity factor adjustment aspect to the pregnancy maintenance has certain function.But the long-lived embryo pill adds the taste side the peptide aspect to be more prominent in depression in, infers the Chinese medicine use "rather the heart to calm the nerves" initially to reduce organism the stress to causeβ-endorphin secretion to reduce is helpful to the pregnancy continuation.
5. Long-lived embryo pills add the taste side and the fetus protection work possibly reduce or the elimination existence blood serum are helpful from the build immune body or the homogeneous foreign body immune body to the pregnancy, but the long-lived embryo pill adds the taste side to add and subtract possibly has the curative effect, also the Chinese medicine treatment compares the western medicine security, does not have the side effect.Is worth further studying.
6. Has the miscarriage or has when the miscarriage symptom the circumference blood NK cell activeness to strengthen the Th1 cell factor the secretion increase, the long-lived embryo pill adds the taste side and the fetus protection works possibly reduces the circumference blood NK cell activeness and reduces the Thl cell factor the secretion, promotes the Th2 cell factor secretion, adjusts the Th1/Th2 cell factor the balance to the Th2 direction displacement, reduces it is helpful to the embryo cell toxicity and the immunity damage function to the pregnancy continuation, but the long-lived embryo pill adds taste Fang Suizheng to add and subtract in this aspect possibly must surpass the fetus protection spirit.
7. Invigorates the kidney the profit to be mad the peaceful embryo Chinese native medicine medication security, to the parent substance non-toxic side effect, an antithetical couplet generation of birth and the growth growth has not affected.But still had further the long time revisit observation and the filial generation intelligence growth situation observation, also needed to carry on aspect and so on reproduction toxicity, heredity toxicity to it further research.
8. Progresses through the review and the summary Chinese medicine all previous dynasties literature and the modern medical research, the motherland medicine thought the kidney empty damages, the vitality insufficient, flushes no matter what damages, the embryo Yuan does not solidify is the main pathogenesis, but the kidney not solid embryo, the spleen loses conserves health causes the embryo Yuan not to solidify is the morbidity key, but the modern medicine miscarries the multi-consideration internal secretion immunity factor about recurrence routine.
方法：
第一部分临床疗效观察
随机选取在湖南中医药大学第二附属医院和湖南省妇幼保健院妇科门诊及住院早期先兆流产、习惯性流产要求保胎中医辨证为肾虚型或肾脾虚弱型的患者和流产不可避免或流产不全要求清宫的患者,妇幼保健科接待的正常孕妇,总共160例,分成4组：寿胎丸加味方治疗组50例,保胎灵治疗对照组50例,流产对照组30例,正常妊娠而未服用保胎药物对照组30例。4组病人同时都口服维生素E：100mg, bid×60天和叶酸：0.4mg, Qd×90天。观察治疗前后的疗效和症候的改变及一般性安全性观察。
第二部分寿胎丸加味方临床治疗内分泌—免疫学调节机理研究
放射免疫法(RIA)检测寿胎丸加味方治疗组例和保胎灵治疗对照组治疗前后血清HCG、P、β-EP的变化并较正常妊娠组比较。放射免疫法(RIA)检测外周血EMAB(抗子宫内膜抗体)、AsAb(抗精子抗体)、ACA(抗心磷脂抗体)的变化。采用ELSIA方法检测外周血NK细胞活性及血TNF-α、IFN-γ、IL-4、IL-10治疗前后的变化。
第三部分保胎治疗后对子代生长发育的初步观察
通过电话、网络或上门随访了部分经保胎治疗后新生儿出生时一般情况包括小儿年龄、性别、分娩时孕周、分娩方式、出生时Apgar评分、喂养方式、食量、情绪、有无先天性疾病、有无新生儿窒息史、颅内出血及其他新生儿期疾病等。出生时的身长、体重、头围、胸围等数据,婴幼儿的营养状况、骨骼发育、脑与颅骨发育及胸廓、胸背肌肉、皮下脂肪与肺的发育等情况。
第四部分文献研究
采用计算机网络技术及其文献检索、流行病学回顾性等研究方法对祖国医学,现代医学以及中西医结合医学关于胎漏、胎动不安及滑胎的病名、病因病机、治疗方法、临床方药研究及当前的临床研究进展进行综述。表明中医药保胎的治疗有良好疗效和优势,值得临床研究和推广。
结果：
第一部分临床疗效观察
50例服用寿胎丸加味方加减治疗后患者经综合疗效判定标准判断,治愈18例,显效17例,有效8例,无效7例,总有效率86%；50例服用保胎灵治疗后患者经综合疗效判定标准判断,治愈12例,显效16例,有效12例,无效10例,总有效率80%；两组有效率均较高,但采用寿胎丸加味方加减治疗后的总有效率(86%)要高于保胎灵对照治疗组(80%),但两组比较,P>0.05,差异无显著意义。而寿胎丸加味方治疗组在改善阴道流血、神疲乏力、夜尿频多方面明显优于保胎灵治疗对照组,且有显著性差异(P<0.05)。两组治疗前后外周血RBC、WBC、HGB, AST、ALT、GGT, CREA、BUN均在正常范围内,前后比较差异统计意义(P>0.05)。
第二部分寿胎丸加味方临床治疗内分泌—免疫学调节机理研究
检测用药前四组血HCG、P的值,记录用药后两用药组血HCG、P的变化,并同时检测同期正常妊娠组的HCG、P值进行比较,流产对照组相对于其他3组,血HCG、P值明显偏低,与其他3组比较,差异具有显著意义(P<0.01),其他3组比较,发生流产症状治疗两组血HCG、P要低于正常妊娠组,但两用药治疗组比较,差异无显著意义(P>0.05),具有可比性。两用药组用药治疗后血HCG、P上升,前后比较差异具有显著意义(P<0.05)；两组治疗后虽较正常妊娠组低,但差异无显著意义(P>0.05)。两用药组治疗前后上升幅度跟正常妊娠组相当,差异无显著意义(P>0.05)。检测用药前四组外周血的值,记录用药后两用药组血β-EP的变化,并同时检测同期正常妊娠组的β-EP值进行比较,流产对照组相对于其他3组,血β-EP值明显增高,与其他3组比较,差异具有显著意义(P<0.01)；其他3组比较,发生流产治疗两组血β-EP仍要高于正常妊娠组,但低于流产组,用药前两治疗组比较,差异无显著意义(P>0.05),具有可比性。两用药组用药治疗后血β-EP降低,前后比较差异具有显著意义(P<0.01)。两组用药治疗前后血AsAb的阳性率比较差异具有统计意义(P<0.05),血EmAb的阳性率比较差异无统计学意义(P>0.05),而血ACA经寿胎丸加味方治疗后阳性率下降,而保胎灵治疗后无改变。流产对照组的NK细胞活性较正常妊娠对照组明显升高(P<0.01),较寿胎丸加味方治疗组和保胎灵治疗组也显著升高(P<0.01),而寿胎丸加味方治疗组和保胎灵治疗组治疗前较正常妊娠对照组也显著升高(P<0.01),两治疗组治疗前后比较NK细胞活性降低,差异具有统计学意义(P<0.01)。已发生流产的流产对照组TNF-α、IFN-γ含量较正常妊娠组明显升高(P<0.01),较两治疗组治疗前比较也显著升高(P<0.01),两治疗组治疗后较妊娠正常组比较也高,差异具有统计意义(P<0.01)。相反,已发生流产的流产对照组IL-4、IL-10含量较正常妊娠组明显偏低(P<0.01),较两治疗组治疗前比较也显著偏低(P<0.01)。
第三部分保胎治疗后对子代生长发育的初步观察
随访已生育46例产妇中,新生儿年龄最大1周岁,最小刚出生1周；其中未有早产儿,足月小样儿,畸形儿等,且都未发生新生儿窒息史、颅内出血等其他情况,母儿均正常。出生时的体重、身长、头围、胸围、臀围跟未采取保胎治疗的新生儿比较,差异无统计学意义(P>0.05)。
第四部分文献研究
通过文献总结和分析,祖国医学对于胎漏、胎动不安及滑胎的认识全面,“肾主生殖”病机主要在肾,滑胎更多责之于肾脾虚弱,寿胎丸临床安胎疗效突出,较西医安胎安全。目前已得到公认。从内分泌免疫方面研究流产和治疗的机理,是目前研究的热点。
结论：
1.寿胎丸加味方和保胎灵均为临床治疗肾虚型胎漏、胎动不安、滑胎的效果肯定有效方药,尤其是在改善临床症状方面寿胎丸加味方加减疗效要优于保胎灵。
2.流产次数越多,再次妊娠流产的可能性更大,保胎治疗的疗效越小,这可能与多次流产损伤子宫内膜有关联,“预培其损”是保胎治疗的关键。
3.血HCG、P检测可作为早孕期判断孕囊、胚胎生长发育和判断预后的参考性指标之一,寿胎丸加味方和保胎灵均具有改善黄体黄体功能,促进血HCG, P的增长有助于妊娠的继续
4.寿胎丸加味方加减和保胎灵均可以降低因应激而升高的β-内啡肽从神经内分泌和免疫因子的调节方面对妊娠的维持产生一定的作用。而寿胎丸加味方在降低内啡肽方面更突出,初步推断中医采用“宁心安神”降低机体的应激使内啡肽的分泌减少而有助于妊娠的继续。
5.寿胎丸加味方和保胎灵均可能降低或消除存在血清自体型抗体或同种异体型抗体而有助于妊娠,而寿胎丸加味方加减更可能有疗效,且中医药治疗较西药安全,无副作用。值得进一步研究。
6.发生流产或出现流产症状时外周血NK细胞活性增强,Th1细胞因子的分泌增加,寿胎丸加味方和保胎灵均可能降低外周血NK细胞的活性和降低Th1细胞因子的分泌,促进Th2型细胞因子的分泌,调节Th1/Th2细胞因子的平衡是以Th2为主导的免疫保护,减轻其对胚胎的细胞毒性和免疫损伤作用而有助于妊娠的继续,而寿胎丸加味方随证加减在此方面可能要优于保胎灵。
7.补肾益气安胎中药用药安全,对母体无毒副作用,对子代出生和生长发育没有影响。但仍需进一步长时间随访观察和子代智力发育情况,也需要对其进行生殖毒性、遗传毒性等方面的进一步研究。
8.通过回顾和总结中医历代文献及现代医学关于流产及治疗的研究进展,祖国医学认为肾脾虚损、气血不足、冲任损伤、胎元不固是主要病机,而肾不固胎,脾失摄养导致胎元不固为发病关键,而现代医学关于复发性习惯性流产多考虑内分泌免疫因素。
Objective:
The system reviews the Chinese tradition medicine and the Western medicine the understanding and the treatment which miscarries to the threatened miscarriage and routine, observes teacher the clinical fetus protection experience to summarize the side-long-lived embryo pill comprehensively to add the taste side addition and subtraction treatment spleen kidney two empty embryos to leak, painful fetal movement, the abortion clinical curative effect, as well as around the treatment the endocrine hormone, the immunity immune body, immunity NK cell activeness and Thl/Th2 cell factor change, discusses its fetus protection by the time from the endocrine-immunology angle the action mechanism, for the rich Chinese medicine theory, the discussion Chinese medicine fetus protection mechanism and the clinical research effective Chinese native medicine compound prescription preparation does the foundational clinical research.Simultaneously also is for teacher in the preliminary animal experimentation foundation the clinical research supplement.
Methods:
The first part Clinical curative effect observation
Stochastic selection in the Hunan Chinese medicine university second affiliated hospital and the Hunan Province women's and children's dispensary gynecology department outpatient service and in hospital early time threatened miscarriage, the routine miscarriage requests the fetus protection Chinese medicine dialectical empty either the spleen kidney two empty patients and miscarries the patient for the kidney who inevitable or the miscarriage not all requests the clear palace, the normal pregnant woman who the mother and child care branch reception embryo works, the altogether 160 examples, divide into 4 groups:The long-lived embryo pill adds the taste side treatment group 50 examples, guarantees the treatment control group 50 examples, miscarries the control group 30 examples, the eukyesia has not taken the fetus protection medicine control group 30 examples.4 group of patients simultaneously all take orally the Vitamin E:100mg, bid×60 day and the folic acid:0.4mg, Qd×90 day.Around observation treatment curative effect and symptom change and general secure observation.
The second part Clinical endocrine internal secretion-immunology research
Emission immunity law (RIA) examines the long-lived embryo pill to add the taste side treatment group example and the fetus protection spirit treatment control group treats blood serum HCG, P,β-EP the change and the eukyesia group comparison.Emission immunity law (RIA) examination circumference blood EMAB (anti-endometrium immune body), AsAb (anti-sperm immune body), ACA (anti-cuorin immune body) change.Uses ELSIA method examination circumference blood NK cell activeness and the blood TNF-α, IFN-γ, IL-4, around the IL-10 treatment change.
Around third part Fetus protection treatment the antithetical couplet generation of growth growth preliminary observation
Through the telephone, the network or visits made a follow-up visit the part after the fetus protection treatment when the newborn birth the ordinary circumstances including when the young child age, the sex, the childbirth is pregnant when the week, the childbirth way, the birth the Apgar grading, feeds the way, the appetite, the mood, whether there is the congenital disease, whether there is the newborn suffocates the history, the skull internal hemorrhage and other newborn time disease and so on.Time the birth height, the body weight, encircle, data and so on chest measurement, babies and infants' nutrition condition, the skeleton growth, the brain and the skull growth and the chest gallery, chest back muscle, hypodermic fat and lung situations and so on growth..
The fourth part Literature research
Uses research techniques and so on computer network technology and literature retrieval, epidemiology review to the motherland medicine, the modern medicine as well as the cooperation of Chinese and Western medicine medicine leaks, about the embryo painful fetal movement and the abortion sickness name, the cause of disease pathogenesis, the method of treatment, clinical Fang Yao studies and the current clinical research progress carries on the summary.Indicated the Chinese medicine fetus protection treats has the good effect and the superiority, is worth the clinical research and the promotion.
Results:
The first part Clinical curative effect observes
50 examples to take the long-lived embryo pill to add the taste side addition and subtraction treatment future trouble after the synthesis curative effect determination standard judgment, cures 18 examples, shows results 17 examples, effective 8 examples, invalid 7 examples, total effectiveness 86%; 50 examples take the fetus protection spirit treatment future trouble after the synthesis curative effect determination standard judgment, cures 12 examples, shows results 16 examples, effective 12 examples, invalid 10 examples, total effectiveness 80%; Two groups of effectiveness are high, after but uses the long-lived embryo pill to add the taste side addition and subtraction treatment total effectiveness (86%) to have to be higher than the fetus protection spirit comparison treatment group (80%), but two groups of differences after Radit analysis, P>0.05, difference not remarkable significance.But the long-lived embryo pill adds the taste side treatment group to improve the vagina to bleed, the god tired strength, a night of frequent micturition many, surpasses the fetus protection spirit treatment control group obviously, also has the significance difference (P>0.05).Around two groups treat circumference blood RBC, WBC, HGB, AST, ALT, GGT, CREA, BUN in the normal range, around the comparison difference statistics significance (P>0.05).
The second part Clinical endocrine internal secretion-immunology
Research examination medication four group of blood HCG, the P value, the recording applies drugs latter two medication group blood HCG, the P change, and simultaneously examines the same time eukyesia group HCG, the P value carries on the comparison, miscarries the control group to be opposite obviously in other 3 groups, blood HCG, the P value somewhat low, compares with other 3 groups, the difference has the remarkable significance (P<0.01), other 3 groups compare, have the miscarriage symptom to treat two group of blood HCG, P must be lower than the eukyesia group, but two medication treatment group compares, the difference not remarkable significance (P>0.05), has the commeasurability.After two medication group medication treatment blood HCG, the P rise, around the comparison difference has the remarkable significance (P<0.01); Although after two groups treat the eukyesia group to be low, but difference not remarkable significance (P>0.05). Around two medication groups treat the rise scope with the eukyesia group quite, difference not remarkable significance (P>0.05).Before the examination medication four group of circumference blood value, the recording applies drugs the latter two medication group bloodβ-EP change, and simultaneously examines the same time eukyesia groupβ-EP the value to carry on the comparison, miscarries the control group to be opposite in other 3 groups, the bloodβ-EP value obvious markup, compares with other 3 groups, the difference has the remarkable significance (P<0.01); Other 3 groups of comparisons, had the miscarriage to treat two groups of blood P-EP still to have to be higher than the eukyesia group, but was lower than the miscarriage group, before the medication two treatment group comparison, the difference not remarkable significance (P>0.05), had the commeasurability. After two medication group medication treatment the blood P-EP reduces, around the comparison difference has the remarkable significance (P<0.01); Two groups'treated the eukyesia group to be still high, but difference not remarkable significance (P>0.05).Around but two group of medication treatments blood AsAb, masculine gender rate comparison difference has the statistical significance (P<0.05) blood ACA to add the taste side treatment after the long-lived embryo pill the masculine gender rate drop, after but the fetus protection spirit treatment does not have changes.The miscarriage control group's NK cell activeness eukyesia control group elevates obviously (P<0,01), the long-lived embryo pill adds the taste side treatment group and the fetus protection spirit treatment group also obviously elevates (P<0.01) around, but the long-lived embryo pill adds the taste side treatment group and the fetus protection spirit treatment group treats the eukyesia control group also obviously to elevate (P<0.01), two treatment groups treats compares the NK cell activeness to reduce, the difference has statistics significance (P<0.01). After two treatment groups treated the eukyesia group to compare still are also high, the difference also had statistics significance (P<0.Ol).Has had the miscarriage miscarriage control group TNF-α, IFN-γthe content eukyesia group elevates obviously (P<0.01) before, two treatment groups treat compare also obviously elevate (P<0.01), after two treatment groups treat compare the eukyesia group to compare also high, the difference has the statistical significance (P<0.01).On the contrary, has had miscarriage miscarriage control group IL-4, the IL-10 content eukyesia group obvious somewhat low (P<0.01) before, two treatment groups treat obviously compare also somewhat low (P<0.01).
The third part Fetus protection treatment the antithetical couplet generation of growth growth preliminary observation
Revisit has given birth in 46 example parturient women, the newborn age is biggest 1 full year old, smallest just was born 1 week; In which has not had the premature infant, the full-term galley proof, abnormal and so on, also all has not had the newborn to suffocate the history, the skull internal hemorrhage and so on other situations, the mother is normal.Time the birth body weight, the height, encircle, the chest measurement, the hips with have not adopted the fetus protection treatment the newborn comparison, the difference non-statistics significance (P>0.05).
The fourth part Literature research
Through the literature summary and the analysis, the motherland medicine leaks, regarding the embryo painful fetal movement and the abortion knows comprehensively, "the kidney host reproduction" the pathogenesis in the kidney, abortion Yu of Pishen more responsibility two empty, the long-lived embryo pill clinical peaceful embryo curative effect is mainly prominent, compares the doctor practicing western medicine peaceful embryo security.At present obtained the recognition. Studies the mechanism from the endocrine-immunity aspect which miscarries and treats, is hot spot which at present studies.
Conclusion:
1. Long-lived embryo pills add the taste side and the fetus protection work leak, for the clinical treatment spleen kidney two empty embryos painful fetal movement, the abortion effect affirmation effective side medicine, in particular adds the taste side addition and subtraction curative effect in the improvement clinical symptom aspect long-lived embryo pill to have to surpass the fetus protection spirit.
2. Miscarriage number of times are more, the pregnancy miscarries once more the possibility is bigger, the fetus protection treatment curative effect is smaller, this possible and miscarries many times damages the endometrium to have the connection, "cultivates it to damage is the fetus protection treatment key in advance".
3. Blood HCG, the P examination may take the early gestation period judgment is pregnant the pouch, the embryo growth grows and judges one of prognosis referential targets, the long-lived embryo pill adds the taste side and the fetus protection works has improves Huang Tihuang the body function, promotion blood HCG, the P growth is helpful in the pregnancy continuation
4. Long-lived embryo pill adds the taste side addition and subtraction and the fetus protection works may reduce theβ-endorphin which elevates because of the stress from the god internal secretion and the immunity factor adjustment aspect to the pregnancy maintenance has certain function.But the long-lived embryo pill adds the taste side the peptide aspect to be more prominent in depression in, infers the Chinese medicine use "rather the heart to calm the nerves" initially to reduce organism the stress to causeβ-endorphin secretion to reduce is helpful to the pregnancy continuation.
5. Long-lived embryo pills add the taste side and the fetus protection work possibly reduce or the elimination existence blood serum are helpful from the build immune body or the homogeneous foreign body immune body to the pregnancy, but the long-lived embryo pill adds the taste side to add and subtract possibly has the curative effect, also the Chinese medicine treatment compares the western medicine security, does not have the side effect.Is worth further studying.
6. Has the miscarriage or has when the miscarriage symptom the circumference blood NK cell activeness to strengthen the Th1 cell factor the secretion increase, the long-lived embryo pill adds the taste side and the fetus protection works possibly reduces the circumference blood NK cell activeness and reduces the Thl cell factor the secretion, promotes the Th2 cell factor secretion, adjusts the Th1/Th2 cell factor the balance to the Th2 direction displacement, reduces it is helpful to the embryo cell toxicity and the immunity damage function to the pregnancy continuation, but the long-lived embryo pill adds taste Fang Suizheng to add and subtract in this aspect possibly must surpass the fetus protection spirit.
7. Invigorates the kidney the profit to be mad the peaceful embryo Chinese native medicine medication security, to the parent substance non-toxic side effect, an antithetical couplet generation of birth and the growth growth has not affected.But still had further the long time revisit observation and the filial generation intelligence growth situation observation, also needed to carry on aspect and so on reproduction toxicity, heredity toxicity to it further research.
8. Progresses through the review and the summary Chinese medicine all previous dynasties literature and the modern medical research, the motherland medicine thought the kidney empty damages, the vitality insufficient, flushes no matter what damages, the embryo Yuan does not solidify is the main pathogenesis, but the kidney not solid embryo, the spleen loses conserves health causes the embryo Yuan not to solidify is the morbidity key, but the modern medicine miscarries the multi-consideration internal secretion immunity factor about recurrence routine.
引文
[1]乐杰.妇产科学[M].第七版,北京：人民卫生出版社.2008：89.
[2]曹泽毅.中华妇产科学[M].第2版,北京：人民卫生出版社.2005：352-361.
[3]郑筱萸.中药新药临床研究指导原则[S](试行),北京：中国医药科技出版社,2002：253-258.
[4]张玉珍.《中医妇科学》[M].十一·五规划教材,北京：中国中医药出版社2008：210,219.
[5]《中医病症诊断疗效标准》.国家中医药管理局[S].南京,南京大学出版社：1994：67-68.
[6]张锡纯.《医学衷中参西录》[M].山西：山西科学技术出版社,2009：372.
[7]王晓敏,王建红,伍庆华,等.菟丝子黄酮对去势雌性大鼠血清雌激素水平和血管平滑肌细胞的影响[J].天津医药2005,33(10)：650-652.
[8]田代华.实用中药辞典[M]..北京：人民卫生出版社,2002：1685-1690.
[9]顾立刚,叶敏,阎玉凝.菟丝子金丝桃昔体内外对小鼠免疫细胞功能的影响[J].中国中医药信息杂.2001,8(11)：42-46.
[10]田代华.实用中药辞典[M]..北京：人民卫生出版社,2002：1871-1873.
[11]孙艳秋,刘珂槲.桑寄生的研究进展[J].中草药,2000,31(6)：471.
[12]高学敏.中药学[M].北京：人民卫生出版社,2000：1785-1790.
[13]刘晓荣.寿胎丸治疗先兆流产100例[J].中医民间疗法.1998,10(5)：93.
[14]朱艳菊.加味寿胎丸治疗先兆流产240例[J].国医论坛.2000,15(4)：22.
[15]郑春霞.寿胎丸合助气补漏汤治疗先兆流产218例[J].河南中医.2002,22(5)：65.
[16]李兵兵,刘维立,陈立怀.寿胎丸加减治疗肾虚型先兆流产36例临床观察[J].吉
林中医药,2008,28(3)：191.
[17]朱金凤.寿胎丸加味治疗先兆流产的临床观察及实验研究[J].中西医结合杂志,1987,7(7)：407.
[18]皇新.寿胎丸加味保胎增智34例分析[J].中国误诊学杂志.2007,7(18)：4368-4369
[19]清·傅山著《傅青主男女科》[M]..北京：中国中医药出版社,1999：55.
[20]张锡纯.《医学衷中参西录》[M]..山西：山西科学技术出版社,2009：412.
[21]庞慧民,朱玉琢,高九春.杜仲对小鼠生殖细胞的遗传毒性[J].中国公共卫生.2006,22(9)：1152.
[22]明·张介宾《景岳全书》[M]..北京：人民卫生出版社,2007：174.
[23]姚荣玉,李琴,余爱丽.药物流产对再次妊娠并发症的影响[J].中华临床医药与护理.2004,10：1-2.
[24]季建媚,孙亮.探讨人工流产与不良妊娠结局的关系[J].浙江临床医学.2009,11(3)：277-278.
[25]邹燕,李幼平,吕琳,等.药物流产对再次妊娠影响的系统评价[J].中国循证医学杂志.2003,3(3)：186-194.
[26]刘超,陈光亮,王钦茂.中药妊娠毒理研究进展(综述)[J].北京中医药大学学报.1998,21(6)：37-39.
[27]覃丹丹,仇小强,张志勇,等.广西2000年出生缺陷环境致畸因素危险度评价[J].环境与职业医学.2004,21(2)：135-138.
[28]刘丹卓,尤昭玲,等.寿胎丸对SD孕鼠生殖功能及其胚胎发育的毒性研究[J].甘肃中医学院学报.2008,25(6)：6-9.
[29]尤昭玲,刘丹卓,等.寿胎丸对CHL细胞株染色体畸变影响的研究[J].湖南中医药大学学报.2008,28(3)：3-4,7.
[30]刘丹卓,尤昭玲,等.养精种玉汤对KM小鼠骨髓细胞微核率的影响[J].山西中医.2009,25(5)：52-56.
[31]许爽君,杨水清,王建萍,等.补肾益冲丸的毒理学实验研究[J].中国中医急症.2007,7：852-853.
[32]刘月凤,符达,袁慧.杜仲提取物的致突变实验研究[J].时珍国医国药.2009,20(3)：679-680.
[33]陆培信,刘冰,董皎.黄芩遗传毒性实验研究[J].白求恩医科大学学报.2001,27(4)：356-357.
[34]杨丽萍,杨幼明,杨钧.黄芩对大鼠胚胎致畸作用的观察[J].中国比较医学杂志.2003,13(3)：155-158.
[35]彭树新,李啸红.桑寄生的遗传毒理学研究[J].中国优生与遗传杂志.2008,16(12)：46-48.
[36]倪文澎,邱召娟.单味黄芪和含黄芪复方的遗传毒性检测[J].中华现代中西医杂志.2004,2(2)：161.
[1]Browning JF, Butt WR, Lynch SS,et al.Maternal plasma concentrations of P-lipotrophin, β-endorphin, andy-lipotrophin throughout pregnancy[J].Br J Obstet Gynecol.1983,90:1147.
[2]Wadhwa PD,Dunkel-SchetterC,Chicz-Denver A,et al.Prenatal paychosocial factors and then euroendocrine axis in human pregnancy[J]. Psychosom Med.1996;58:432.
[3]Nakamura H,Seto T,Nagase H,et al. Inhibitory effect of pregnancy on stressinduced immunosuppression through corticotrophin releasing hormone (CRH) and dopaminergic systems[J]. J Neuro Immunol.1997;75:1.
[4]Sandman CA,Wadhwa PD,Chicz-Demet A,et al. Maternal stress, HPA activity and fetal/infant outcome[J].Ann N Y Acad Sci,1997;814:266.
[5]Hatasaka HH,Recurrent miscarriage, epidemiologic factors, definitions and incidence[J].Clin Obstet Gynecol.1994;37:625.
[6]马红霞,尤昭玲,王若光.菟丝子总黄酮对大鼠流产模型血清P. PR、Th1/Th2细胞因子表达的影响[J].中药材.2008,31(8)：1201-1204.
[7]金志春张敦兰王旭莹周可为彭敏王晓红芦劲代莉韩少云肖丽达.药流安颗粒对早孕药流妇女血清激素PRL E2 P T β-hCG水平的影响[J].辽宁中医杂志.2007,34(8)：13-15.
[8]李予,张清学,杨冬梓,麦美琪.胚胎移植后14天单次血HCG预测妊娠结局的探讨[J].实用妇产科杂志.2005,21(8)：483-485.
[9]李明勋梁艳楠张明.孕晚期母血HCG、HPL及HCG/HPL比值异常与不良妊娠结局关系的研究[J].齐齐哈尔医学院学报.2007,28(8)：916-917.
[10]冯立娟,陆学媚.保胎灵I号治疗反复自然流产对母体免疫平衡及内分泌功能的影响[J].中国医药导报.2008,10(7)：1042-1044.
[11]丁亚军,陈意振,宋逸民,屠越坷.内啡肽在先兆流产孕妇中变化的初步观察[J].中国优生与遗传杂志.2001,9(2)57-58.
[12]Sandman CA, Wadhwa PD, Chicz DA, et al. Maternal stress, HPA activity and fetal/infant outcome[J]. Ann N Y Acad Sci.1997,814:266-280.
[13]孙斐,俞瑾.中药治疗先兆流产对血浆p-内啡肽和胎盘内分泌的影响[J].中国中西医结合杂志.1999,19(2)：87-89.
[14]Mathews PM. Enhancement of natural cytotoxicity by β-endor-phin[J] J Imunul.1983,30:1658-1662.
[15]国家中医药管理局.中华本草[M].上海；上海科学技术出版社,1996：1556-1558
[16]钟向真.自身免疫型习惯性流产的临床治疗[J].中国优生与遗传杂志.2006,14(11)：38-42.
[17]张士芬,陆启滨.抗心磷脂抗体与反复自然流产的研究进展[J].深圳中西医结合杂志.2003,13(2)：78.
[18]Meek S C et al.Auto immunity in infertile patients with endometrosis[J]. Am J Obstet Gynecol.1998,158-165.
[19]沈丽萍,金洁,程建军,等.抗精子抗体和抗子宫内膜抗体与反复自然流产关系研究[J].实用临床医学杂志.2007,13(1)：35.
[20]王越,王金龙.习惯性流产免疫学病因的研究进展[J].国外医学：妇产科分册.2005,28(6)：591-593.
[21]林其德.复发性流产免疫学诊断和治疗共识[J].生殖医学杂志.2008,17(1)：4-6.
[22]张涛,李伟莉,陈丽娟.中医药治疗免疫性流产研究进展[J].中医药临床杂志.2008,20(1)：97-99.
[23]王昕.中医治疗抗心磷脂抗体阳性习惯性流产43例分析[J].中医药学刊.2004,22(5)：945.
[24]叶利群.补肾活血法合阿司匹林治疗ACA阳性复发性流产45例[J].江西中医药.2008,39(10)：63-64.
[25]俞调忠.中药促AsAb、EmAb阳性转阴70例临床观察[J].江苏中医药.2003,24(10)：36-37.
[26]Kammerer, U, Marzusch, K, Krober, S. et al. A subset of CD56+ large granular lymphocytes in first-trimester human deciduas are proliferating cells [J]. Fertil Steril.1999,71:74-79.
[27]Coulam-CB,Goodman-C,et al.Systemic CD56+cells can predict pregnancy outcome[J].Am-J-Reprod-Immunol.1995,33(1):40-46.
[28]赵卫秀,林其德.正常妊娠早期孕妇外周血自然杀伤细胞亚群的变化[J].中华妇产科杂志.1998,33：362.
[29]李敏,高瑞珍,赵淑霞,等.自然流产患者外周血与蜕膜组自然杀伤细胞亚群数量变化的研究[J].中国优生与遗传杂志.2001,9(6)：50-53.
[30]陈巧儿,秦卫兵,杨宁,叶嘉玲.免疫治疗原因不明反复自然流产后Thl/Th2型细胞因子和NK细胞的变化[J].中国妇幼保健.2005,20(20)：2637-2639.
[31]余进胜,彭来勤,张丙忠.复发性自然流产患者NK细胞活性变化的研究[J].广州医药.2004,35(3)：35-37.
[32]王海燕,王振海.蜕膜NK细胞与自然流产[J].国外医学计划生育分册.1998,7(3)：149-152.
[33]D. Rastogi, C. Wang, C. Lendor,et al. T-helper type 2 polarization among asthmatics during and following pregnancy[J].Clin Exp Allergy.2006,36(7):892-898
[34]Kwak-Kim J,Lee S K,Gilman-Sachs A,et al,Elevated Thl/Th2 cell ratios in a pregnant woman with a history of RSA,secondary Sjogren's syndrome and rheumatoid arthritis complicated with one fetal demise of twin pregnancy [J]. Am J Reprod Immunol.2007,58(4):325-329.
[35]夏革清, 王泽华, 吴超英.Th1/Th2型细胞因子在不明原因早期自然流产绒毛和蜕膜组织中的表达[J].实用医学杂志.2009,25(17)：2852-2854.
[36]Kwak-Kim J,Lee S K,Gilman-Sachs A.Elevated Thl/Th2 cell ratios in a pregnant woman with a history of RSA,secondary Sj(o)gren's syndrome and rheumatoid arthritis complicated with one fetal demise of twin pregnancy[J].Am J Reprod Immunol.2007,58(4):325-329.
[37]De-Punzio C, Neri E, Metelli P, et al. The relationship between maternal relaxation and plasma beta-endorphin levels during parturition[J]. Psychosom Obstet ecol.1994,15(4):205-210.
[38]胡电,古航,洪新如,刘彦,金志军,王成海,曹立萍,内源性阿片肽在正常妊娠和分娩中的变化[J].第二军医大学学报.2003,24(3)：311-313.
[39]Fajardo MC, Florido J, Villaverde C, et al. Plasma levels of beta-endorphin and ACTH during labor and immediate puerperiam[J]. Eur J Obstet Gsmecol Reprod Biol.1994,55(2):105-108.
[40]孙斐,严敦清,张崇理,俞瑾.早期先兆流产妇女血浆p-内啡肽的研究[J].生殖医学杂志.1998,7(3)：141-144.
[41]丁亚军.陈意振,宋逸民.屠越坷.内啡肽在先兆流产孕妇中变化的初步观察[J].中国优生与遗传杂志.2001,9(2)：57-58.
[1]侯家玉.中药药理学[M].北京：中国中医药出版社.2002：30,31,32.
[2]骆和生,罗鼎辉,主编.免疫中药学[M].北京：北京医科大学/中国协和医科大学联合出版社,1999：87.
[3]裴小静.对促孕、保胎、催乳相关中药与子代安全性问题的思考[J].中国中药杂志.2008,33(22)：2719-2720.
[4]中の敬吾.妊娠期服用当归芍药散患者的随访调查[J].国外医学中医中药.1984,(6)：27.
[5]国凤容.寿胎丸治疗先兆流产和习惯性流产对娩出之婴幼儿的细胞遗传学研究[J].辽宁中医杂志.1984,(10)：22.
[6]张玉珍.中医药防治自然流产的追踪调查[J].新中医.1990,(4)：55-56.
[7]杨成林.先兆流产经中医药保胎小儿智能发育的调查.中国中西医结合杂志[J].1992,(3)：175.
[8]归绥琪,曹玲仙,毛秋芝,等.补肾益气清热法治疗先兆流产及对小儿的影响[J].上海中医药杂志.1995,(3)：12-13.
[9]董燕赵颖.补肾健脾中药安胎后对子代智力和体格发育的影响[Jl.新乡医学院学报.2007,24(5)：477-479.
[10]覃丹丹,仇小强,张志勇,等.广西2000年出生缺陷环境致畸因素危险度评价[J].环境与职业医学.2004,21(2)：135-138.
[11]刘丹卓,尤昭玲,等.寿胎丸对SD孕鼠生殖功能及其胚胎发育的毒性研究『J].甘肃中医学院学报.2008,25(6)：6-9.
[12]尤昭玲,刘丹卓,等.寿胎丸对CHL细胞株染色体畸变影响的研究[Jl.湖南中医药大学学报.2008,28(3)：3-4,7.
[13]刘丹卓,尤昭玲,等.养精种玉汤对KM小鼠骨髓细胞微核率的影响[J].山西中医,2009,25(5)：52-53,56.
[14]许爽君,杨水清,王建萍,等.补肾益冲丸的毒理学实验研究[J].中国中医急症,2007,7：852-853.
[15]刘月凤,符达,袁慧.杜仲提取物的致突变实验研究[J].时珍国医国药.2009,20(3)：679-680.
[16]陆培信,刘冰,董皎.黄芩遗传毒性实验研究[J].白求恩医科大学学报.2001,27(4)：356-357.
[17]杨丽萍,杨幼明,杨钧.黄芩对大鼠胚胎致畸作用的观察[J].中国比较医学杂志.2003,13(3)：155-158.
[18]彭树新,李啸红.桑寄生的遗传毒理学研究[J].中国优生与遗传杂志,2008,16(12)：46-48.
[19]倪文澎,邱召娟.单味黄芪和含黄芪复方的遗传毒性检测[J].中华现代中西医杂志.2004,2(2)：161.
[20]皇新.寿胎丸加味保胎增智34例分析[J].中国误诊学杂志.2007,7(18)：4369-4370.
[1]胡厚宣,<殷人疾病考>,《学思》[M]1934,(3)：34.
[2]刘敏如主编,《中医妇科学》[M],北京：人民卫生出版社,2006：260,281.
[3]汉·张仲景《金匮要略》[M]北京：人民卫生出版社,2009：77.
[4]晋·王叔和《脉经》[M]上海：科学技术出版社,2005：67.
[5]隋·巢元方《诸病源候论》[M]北京：人民卫生出版社,1959：482.
[6]明·李梃《医学入门》[M]北京：人民卫生出版社,2006：863.
[7]明·武之望《济阴纲目》[M]北京：人民卫生出版社,2006：32.
[8]宋·陈自明《妇人大全良方》[M]北京：人民卫生出版社,2005：114.
[9]清·叶桂《叶氏女科证治》[M]上海：锦章书局,1955：15.
[10]清·吴谦《医宗金鉴》[M]北京：人民卫生出版社,2005：65.
[11]唐·孙思邈《备急千金要方》[M]北京：人民卫生出版社,2005：27.
[12]宋·齐仲甫.女科百问.见：《精选中医妇科名著》[M]北京：中国中医药出版社，1996：498.
[13]明·王纶《明医杂著》[M]北京：中国中医药出版社,2009：90.
[14]明·万全《万氏家传广嗣纪要》[M]湖北：湖北科学技术出版社,1986：69.
[15]明·张介宾《景岳全书》[M]北京：人民卫生出版社,2007：817.
[16]元·朱震亨《格致余论》[M]北京：人民卫生出版社,2007：76.
[17]清·王清任《医林改错》[M]北京：人民卫生出版社,2007：35.
[18]清·陈梦雷《古今图书集成医部全录第九册妇科》[M]北京：人民卫生出版社,1995：56.
[19]唐·昝殷《经效产宝》[M]北京：人民卫生出版社,2007：18.
[20]唐·王焘《外台秘要》[M]北京：人民卫生出版社,2000：34.
[21]宋·朱端章《卫生家宝产科备要》[M]上海：上海古籍出版社,2004：37.
[22]元·朱震亨《丹溪心法》[M]北京：人民卫生出版社,2007：295.
[23]明·王肯堂《证治准绳》[M]北京：人民卫生出版社,2001：67.
[24]清·傅山《傅青主男女科》[M].北京：中国中医药出版社,1999：43.
[25]张锡纯《医学衷中参西录》[M].山西：山西科学技术出版社,2009：89.
[26]胥受天主编.《中医妇科学》[M].上海：上海科学技术出版社,1980：5.
[27]哈荔田.《哈荔田妇科医案医话选》[M].天津：天津科技出版社,1982：17.
[28]罗元恺.《百科全书·中医妇科学》[M].上海：上海科学技术出版社,1983：328.
[29]宋光济.安胎六法在妇科临床的应用[J].上海中医药杂志.1989,(3)：9.
[30]马宝璋.试论安胎必补肾兼调养气血[J].中医药学报.1988,(1)：34.
[31]王自平.妊娠早期出血辨证施治[J].中原医刊.1987,(3)：3.
[32]周咏芳.胎漏证治之体会[J].湖南中医杂志.1986,(3)：28-29.
[33]宓伟毅.加味二至九治疗先兆流产131例[J].浙江中医杂志.1998,3(4)：161.
[34]张莹,李玛建,涂序珉.养血安胎颗粒对反复自然流产患者非孕期NK及Ts细胞活性的影响[J].中国优生与遗传杂志.2006,14(6)：55-66.
[35]蔡丽慧,赵卫.中西医结合治疗免疫性反复性早期流产56例分析[J].中医药学刊.2002,20(4)：39.
[36]应震红,章以森.中西医结合治疗ABO血型不合疗效观察[J].实用中医药杂志.2004,20(6)：315.
[37]莫蕙,郭慧红.免疫性不孕(AsAb阳性)中医病机探讨[J].南京中医药大学学 报.1998,19(12)：8.
[38]罗颂平,张玉珍.免疫性自然流产与免疫性不孕的临床与实验研究[J].中医杂志.1997：38(6)：351.
[39]王云凤,陆启斌.补肾活血法治疗抗心磷脂抗体阳性免疫性流产的研究[J].甘肃中医.2008,21(1)：8-9.
[40]林苑琪,林茂彦,林进雄.论保胎之补脾益肾与活血化瘀[J].中华中医药学刊.2007,25(3)：546-547.
[41]张玉珍.罗元恺教授经验方“滋肾育胎丸”临床总结(附150例疗效分析)[J].新中医杂志[.1983,(3)：11.
[42]阎乐法,刘锐.调免1号治疗免疫异常增高型反复自然流产临床研究[J].山东中医杂志.2005,24(12)：717-718.
[43]景苏玉,归绥祺.“保胎1冲剂”提高反复自然流产患者免疫功能的临床观察[J].上海中医药杂志.2002,(9)：23-24.
[44]吴宁,张桂荣.中药复方优生宁对先兆流产病人免疫功能的影响[J].哈尔滨商业大学学报.2002,18(1)：43-44.
[45]孟安琪,王岩.抗自然流产颗粒治疗抗心磷脂抗体导致流产33例观察[J].中医药学刊.2005,23(12)：2211-2213.
[46]卫爱武,李颖.中西医结合治疗抗磷脂抗体致反复性流产30例[J].四川中医.2004,22(9)：57-59.
[47]郝琳,孙立峰,孙立芳.育孕保胎胶囊治疗先兆流产210例临床观察[J].河北中医.2005,27(5)：339-340.
[48]张丽蓉,习惯性流产针灸治疗558例.世界针灸学会联合会成立暨第一届世界针灸学术大会论文摘要选编[C]；1987年
[49]梁静霞,谢感共.灵龟八法及针刺治疗先兆流产60例疗效观察[J].深圳中西医结合杂志.2005,15(2)：106.
[50]朱惠云.中药内服外敷治疗先兆流产260例[J].广西中医药.2001,24(4)：43.
[51]赵伟.脐疗法配合胎元饮治疗先兆流产30例[J].河南中医.2007,27(9)：51.
[52]肖俊芳.穴位注射治疗习惯性流产22例[J].中国针灸.2000,8：60.
[53]梁兆松.先兆流产多因虚药粥保胎功效奇[J].药膳食疗.2005,4：7.
[54]刘显磊,罗颂平,梁国珍,等.助孕3号方及拆方防治肾虚黄体抑制动物流产模型的实验研究[J].生殖与避孕.2003,23(1)：17-22.
[55]孙斐,俞瑾.中药治疗先兆流产对血浆β-内啡肽和胎盘内分泌的影响[J].中国中西医结合杂志.1999,19(2)：87-89.
[56]吴宁,贾长茹,单丽艳.优生宁对先兆流产病人内分泌功能的影响[J].中医药学报.2000,28(2)：25-26.
[57]张剑峰,归绥琪.中药治疗对反复自然流产患者抗CD抗原封闭效率和血清泌乳素及孕酮的影响[J].中国中西医结合杂志.2004,24(4)：303-305.
[58]赵薇,陈霞.滋肾柔肝法对先兆流产患者体内性激素的影响[J].辽宁中医杂志.2002,29(1)：38-39.
[59]韩慧,罗颂平.助孕3号方对大鼠子宫收缩活动的影响[J].第八届全国中医妇科学学术交流大会论文集.2000,219-222.
[60]崔晓萍,胎儿安冲剂治疗先兆流产的止血作用实验研究[J].陕西中医学院学报.2003,26(3)：38-40.
[61]李应全,徐红岩,张斌,等.固胎液的药效学研究[J].山东医药工 业.2000,19(5)：43-44.
[62]水正,陈华英,柴阿园.少腹逐汤治疗先兆流产68例观察[J].吉林中医药.2003,23(4)：19.
[63]曹立幸,韩冰,李同玺,等.益气养血、固肾安胎法对肾虚流产免疫因素影响的实验研究[J].天津中医.2001,18(5)：35.
[64]周英,罗颂平,许丽绵,等.助孕3号方对肾虚黄体抑制流产大鼠母胎界面Th1/Th2细胞因子的影响研究.现代中西医结合杂志[J].2008,17(1)：12-14.
[65]蒋立辉,归绥琪,李昆明,等.中药对溴隐亭致流产大鼠保胎机理的实验研究[J].中国免疫学杂志.2002,18(10)：105.
[66]顾文平.安胎养血方治疗先兆流产68例[J].浙江中医学院学报.2006,30(1)：32.
[67]乐杰.妇产科学[M].第七版,北京：人民卫生出版社,2008：89.
[68]王少花,王霞.妇产科合理用药[M].第一版,北京：人民卫生出本社,2004：46.
[69]俞霭峰.妇产科内分泌学下册[M].上海科技教育出版社,1985：145.
[70]汪宏波,占海英,李红发.黄体功能不全患者着床期子宫内蒙雌孕激素受体的表达及超微结构改变[J].中国妇幼保健.2004,19(6)：44-46.
[71]周传清,郭慧兰,尚学瑞.绒毛膜促性腺激素治疗黄体功能不足所致流产[J].中国实用医药.2007,2(25)：45.
[72]曹泽毅.中华妇产科学[M].北京：人民卫生出版社.2005：599.
[73]Sbracia M, Mastrone M, Scarpellini F, et al. Influence of histocompatibility antige ns in recurrent spontaneous abortions and on their reproductive perforfamce[J]. Am J Repord Immunol.1996,35:85-92.
[74]Kishore R, Agarwal S, Halder A, et al. HLA sharing, anti-paternal cytotoxic antib odies and MLR blocking factors in women with recurrent spontaneous abortion[J]. J Obstet Gynecol Res.1996,22(2):177-183.
[75]林其德.复发性流产免疫学诊断和治疗共识[J],生殖医学杂志,2008,17(1)：4-6.
[76]袁耀警,盛丹青.妇产科学新理论与新技术[J],上海科技教育出版社.1996：568.
[77]Yao J, Milliez J, Netter A, et al. J Gynecol Obstet Biol Repord, 1997,26(3):304-308.
[78]张世训,宋永红,吕红娟.免疫疗法在原因不明习惯性流产中的应用[J].临床输血与检验.2004,6(3)：196-203.
[79]吴晓黎,陈新玲,徐明华.原因不明的习惯性流产患者的免疫治疗[J].中华现代临床医学杂志.2005,3(20)：17-21.
[80]韩宝生,孙琳杰,吴剑华.反复自然流产的免疫因素分析探讨[J].中国优生与遗传杂志.2003,(4)：193-196.
[81]沈小红,周婕.免疫因素与反复自然流产的关系[J].中华医学实践杂志.2004,3(12)：308.
[82]钟向真.自身免疫型习惯性流产的临床治疗[J].中国优生与遗传杂志.2006,(11)：38-42.
[83]张士芬,陆启滨.抗磷脂抗体与反复自然流产的研究进展[J].深圳中西医结合杂志.2003,13(2)：78.
[84]Meek S C et al.Autoimmunityi ninfertile patients with endometrosis[J].Am J Obstet Gynecol.1998;158-165.
[85]沈丽萍,金洁,程建军,等.抗精子抗体和抗子宫内膜抗体与反复自然流产关系研究[J].实用临床医学杂志.2007,13(1)：35.
[86]王越,王金龙.习惯性流产免疫学病因的研究进展[J].国外医学：妇产科分册.2006,28(6)：591-593.
[87]李大金.生殖免疫学[M],十一五规划教材,上海：复旦大学出版社.2008：145.
[88]何亚平,岳利民,张金虎,等.抗生殖抗体与女性不孕的关系[J].现代预防医学.2000,27(1)：69-71.
[89]郭辉,王庆荣,张朝霞.反复流产的免疫学研究进展『J].中国优生与遗传杂志.2008,16(2)：127-128.
[90]Matalon ST, Blank M, Levy Y.et al. The pathogenic role of anti-thyroglobulin antibody on pregnancy:evidence from an active immunization model in mice[J]. Hum Reprod.2003,18(5):1094-1099.
[91]邱丽华.原因不明复发性流产与Thl／Th2型细胞因子[J].国外医学·计划生育分册.2000,19(1)：20-23.
[92]D. Rastogi, C. Wang, C. Lendor,et al. T-helper type 2 polarization among asthmatics during and following pregnancy[J].Clin Exp Allergy.2006,36(7):892-898.
[93]罗丽兰.不孕与不育[M],北京：人民卫生出版社.2007：315.
[94]王淑贞主编.妇产科理论与实践[M]第2版,上海：上海科学技术出版社.1991：847
[95]刘素青,王爱玲,王帆.黄体酮联合HCG治疗不明原因习惯性流产98例[J].陕西医学杂志.2004,33(2)：164-165.
[96]小林凉一 他产妇人の科[M].世界1990；42：49.
[97]Ellen J.Immunization as therapy for recurrent spontaneous abortion:A review and meta-analysis[J].Obstet Gynecol.1993,82(5):854-859.
[98]Daya S,Gunby J,Clark DA. Intravenous immunoglobulin therapy for recurrent spontaneous abortion:a meta-analysis[J]. American Journal of Reproductive Immunology.1998(2):69-76.
[99]Katz I, Fisch B, Amit S, et al. Cutaneous graft-versus-host-like reaction after paternal lymphocyte immunizationfor prevention of recurrent abortion[J]. Fertil steril.1992,57(4):927-929.
[100]钟向真.自身免疫型习惯性流产的临床治疗[J].中国优生与遗传杂志.2006,14(11)：38-42.
[101]张士芬,陆启滨.抗磷脂抗体与反复自然流产的研究进展[J].深圳中西医结合杂志.2003(2)：78.
[102]卢春芬.心理干预在先兆流产治疗中的作用[J].现代中西医结合杂志.2007,16(12)：1693-1694.
[103]卢春芬.音乐疗法在先兆流产治疗中的疗效观察[J].解放军护理杂志.2007,24(4)：96.
[104]匡丽君,匡继林.中西结合治疗早期先兆流产临床观察[J].中华中医药学刊,2007,25(7)：1527.
[105]谢一红,胡慧娟.中西医结合孕前孕后并治复发性流产69例临床观察[J].浙江中医杂志.2008,43(8)：457-458.
[106]邓卫红,中西医结合治疗妊娠早期先兆流产100例疗效观察[J].浙江中医杂志.2009,44(2)：117-119.
[107]何志华,车盼芬.中西医结合治疗先兆流产的临床研究及对分娩结局的观察[J].2007,7(2)：32-35
[108]朱巧玲,李淑华.中西医结合治疗早期先兆流产137例[J].甘肃中医.2009,24(4)：45-46.
[109]谢一红,胡慧娟.中西医结合孕前孕后并治复发性流产69例临床观察[J].浙江中医杂志.2008,43(8)：457-458.
[110]陈萍.中西医综合治疗复发性自然流产143例分析[J].中国误诊学杂志.2008,8(22)：5422-5423.
[111]张立青.中西医结合治疗习惯性流产43例临床观察[J].甘肃中医.2009,28(2)：122-123.
[112]叶利群.补肾活血法合阿司匹林治疗ACA阳性复发性流产45例[J].江西中医药.2008,39(10)：63-64
[113]李鹤梅.中西医结合治疗ABO母儿血型不合的临床研究[J].中华临床医学研究杂志.2007,13(14)：2078-2079.
[114]王雅琴.中西医结合治疗ABO母儿血型不合习惯性流产102例[J].河北中医.2009,31(8)：1188-1190.
[115]李卫红.中西医结合治疗支原体感染反复自然流产[J].四川中医.2006,24(1)：86-87.
[116]钟学礼主编.内分泌代谢病学[M].上海：上海科学技术出版社.1984：21.
[117]Browning JF, Butt WR,Lynch SS,et al, Maternal plasma concentrations of β-lipotrophin, β-endorphin, and y-lipotrophin throughout pregnancy[J],Br J O bstet Gynecol.1983;90:1147.
[118]池芝盛编译.内分泌学基础与临床[M].北京：北京协和医院,1987：4.
[119]Terzic M,Sulvic V,Stimec B, et al. The role of beta-endorphin in pregnancy and delivery[J].Clin Exp Obstet Gynecol.1995;22:43.
[120]Browning JF, Butt WR, Lynch SS,et al.Maternal plasma concentrations of β-lipotrophin,β-endorphin,and γ-lipotrophin throughout pregnancy[J]. Br J Obstet Gynecol.1983,90:1147.
[121]Wadhwa P D,Dunkel-SchetterC,Chicz-Denver A, et al.Prenatal paychosocial factors and then euroendocrine axis in human pregnancy[J]. Psychosom Med.1996;58:432.
[122]Nakamura H,Seto T,Nagase H,et al. Inhibitory effect of pregnancy on stressinduced immunosuppression through corticotrophin releasing hormone (CRH) and dopaminergic systems[J]. J Neuro Immunol.1997;75:1.
[123]Sandman CA,Wadhwa PD,Chicz-Demet A,et al. Maternal stress, HPA activity and fetal/infant outcome[J]. Ann N Y Acad Sci.1997;814:266.
[124]Hatasaka HH,Recurrent miscarriage, epidemiologic factors, definitions and incidence[J].Clin Obstet Gynecol.1994,37:625.
[125]孙斐,严敦清,张崇礼,等,早期先兆流产妇女血浆p-内啡肽的研究[J].生殖医学杂志,1998,7(3)：141-144.
[126]丁亚军,陈意振,宋逸民.等.β-内啡肽在先兆流产孕妇中变化的初步观察[J].中国优生与遗传杂志.2001；9(2)：57.
[127]Neale DM,Mor GThe role of Fas mediated apoptosis in preeclampsi[J]a.J Perinat Med.2005,33(6):471-477.
[128]Shimoya K,Matsuzaki N,Taniguchi T,et al.Human placenta consti-Tutively produces mterleulin-8 during pregnancy and enhances its production in intrauterine infaction[J].Biol Reprod.1992,47:220.
[129]Raghupathy R,Makhseed M,Azizieh F,et al.Maternal Th1- and Th2-type reactivity to placental antigens in normal humanpregnancy and unexplained recurrent spontaneous abortions[J].Cell Immunol.1999,196(2):122-130.
[130]Makhseed M,Raghupathy R,Azizieh F,et al.Mitogen-in-duced cytokine responses of maternal peripheral blood lymphocytesindicate a differential Th-type bias in normal pregnancy and pregnancy failure[J].Am J Reprod Immunol.1999,42 (5):273-281.
[131]董琳,朱晓勇,杜美蓉,等.环孢霉素A对小鼠自然流产模型外周CD4+CD25+T细胞及妊娠结局的影响[J].现代免疫学.2006,26(2)：113-115.
[132]邢福祺,孔令红.肿瘤坏死因子α与γ干扰素诱导人绒毛膜滋养层细胞凋亡的研究[J].中华妇产科杂志.1999,34(8)：476-478.
[133]Tangri S, Wegmann TG, Lin H, et al. Maternal anti-placentalrea ctivity in natural immunologically-mediated fetal resorptions[J] J Immunol.1994,152:4903.
[134]Polgar K, Patrick W Yacono BS, et al. Immune interferon gamma inhibits translational m -obility of aplasma membrane protein in preimplantation stage mouse embryos:A T-helper 1 m -echanism for immunologic reproductive failture[J]. Am J Obstet Gynecol.1996,174:282.
[135]CupurdijaK,Azzola D,HainzU,et al.Macrophages ofhuman first trimester decidua express markers associated to alternative activation[J].Am J Reprod Immunol.2004,51 (2):117-220.
[136]Chaout QBafaile N L,Dubanchet S,et al.Reprod immunol 2003:reassessing the Thl/Th2 paradigm[J]. Immunol Lett,2004,92:207-214.
[137]Szekeres-Bartho J,Wegmann TG.A progesterone-dependent immuno modulatory protein alters the Thl/Th2 balance[J]. J Reprod Immunol.1996,31(1-2):81-95.
[138]Saito S, Umekage H, Nishikawa K, et al. Interlenkin 4(IL-4) block the IL-2 induced i -ncrease in natural killer activity and DNA synthesis of decidual CD16-CD56brightNK cells by in habiting expression of the IL-2 receptor α、βand γ[J].Cell Immunol.1996,170:71.
[139]Duelos AJ, Haddad EK, Baines MG. Presence of activated macrophages in a murine model of early embryo loss[J].Am J Reprod Immunol.1995,33:354.
[140]Haddad EK, Duclos AJ, Lapp WS, et al. Early embryoloss is associated with the prior expression of macrophage activation markers in the decidua[J]. J Immunol.1997,158:4886.
[141]Hill JA,Polgar k,Anderson DJ,et al.T-heiper Ⅰ-typer imunty totropho Mast in woman with recurrent spontaneous abortion[J] JAMA.1997,273 (24):1933.
[142]Paradisi R,Porcu E,Venturoli S,et al.Maternal serum levels of pro-inflammatory cytokines in missed and threatened abortion[J].Am J Reprod Immunol. 2003,50(4):302.
[143]孙琪,王秀华.IL-10对人滋养层细胞中HLA-GmRNA表达和HCG分泌的影响[J].实用妇产科杂志.2004,20(1)：46.
[144]刘慧萍,尤昭玲,雷磊,等.寿胎丸对反复自然流产模型小鼠母胎界面TNF-a mRNA和IL-4mRNA表达的影响[J].中医药导报.2008,14(10)：4-7.
[145]Paulesu L,Romagnoli R,Fortino V,et al.Distribution of type-1 interferon-receptors in human first trimester and term placental tissues and on isolated trophoblast cells[J].Am J Reprod Immunol.1997,37 (6):443-448.
[146]Wilson R,Jenkins C,Miller H,et al.Abnormal cytokinelevels in non-pregnant women with a history of recurrent mis-carriage.Eur J Obstet Gynecol Reprod Biol[J].2004,115(1):51-54.
[147]Hill JA 3rd,Choi BC.Immunodystrophism:evidence for a novel alloimmune hypothesis for recurrent pregnancy loss involving Th2-type immunity to trophoblast[J].Semin Reprod Med.2000,18(4):401-405.
[148]Loke YW,K ing A.Immunology of human placental implantation:clinical implications of our current understanding. Molecular Medicine Today[J].1997,3(4):153-159.
[149]King A,Luke YW, Chaoat G.NK cells and reproduction. Immunology Today[J]. 1997,18(2):64-66.
[150]Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F,Masch R Lockwood CJ, Schachter AD,Park PJ, Strominger JL.Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential[J]. Journal of Experimental Medicine 2003,198(8):1201-1212.
[151]Kwak JYH, Beaman KD,Gilman-Sachs A, Ruiz JE,Schewitz D,Beer AE.Up-regulatede xpressiono fC D56+,C D56+/CD56,and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses[J].Am J Reprod Immunol.1995,34:93-99.
[152]Higucbi K,Aoki K,Kimbara T,Hosoi N,Yamamoto T,Okada H.Suppression of natural killer cell activity by monocytes following immunotherapy for recurrent spontaneous aborters[J].Am J Reprod Immunol.1995,33:221-227.
[153]Chao KH,Yang YS,Ho HN,Chen SU,Chen HF, Dai HJ, Huang SC, Gill TJ 3rd. Decidual natural killer cytotoxicity decreased in normal pregnancy but not in anembryonic pregnancy and recurrents pontaneous abortion[J].American Jounral of Reproductive Immunology.1995,34(5):274-80.
[154]Aoki K, Kajiura S, Matsumoto Y, et al, Preconceptional natural-killer-cell activity as a predictor of miscarriage[J]. Lancet.1995,345:1340-1342.
[155]Emmer PM,Veerboek M,Nelen WL, Steegers EA, Joosten I. Natural killer cell reactivity and HLA-G in recurrent spontaneous abortion[J]. Transplant Proc.1999,31:1838-1840.
[156]Yamada H,Morikawa M,Kato EH,Sbimada S,Kobashi QMinakami H. Preconceptional natural-killer-cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype[J]. Am J Reprod Immunol.2003,50(4):351-354.
[2]曹泽毅.中华妇产科学[M].第2版,北京：人民卫生出版社.2005：352-361.
[3]郑筱萸.中药新药临床研究指导原则[S](试行),北京：中国医药科技出版社,2002：253-258.
[4]张玉珍.《中医妇科学》[M].十一·五规划教材,北京：中国中医药出版社2008：210,219.
[5]《中医病症诊断疗效标准》.国家中医药管理局[S].南京,南京大学出版社：1994：67-68.
[6]张锡纯.《医学衷中参西录》[M].山西：山西科学技术出版社,2009：372.
[7]王晓敏,王建红,伍庆华,等.菟丝子黄酮对去势雌性大鼠血清雌激素水平和血管平滑肌细胞的影响[J].天津医药2005,33(10)：650-652.
[8]田代华.实用中药辞典[M]..北京：人民卫生出版社,2002：1685-1690.
[9]顾立刚,叶敏,阎玉凝.菟丝子金丝桃昔体内外对小鼠免疫细胞功能的影响[J].中国中医药信息杂.2001,8(11)：42-46.
[10]田代华.实用中药辞典[M]..北京：人民卫生出版社,2002：1871-1873.
[11]孙艳秋,刘珂槲.桑寄生的研究进展[J].中草药,2000,31(6)：471.
[12]高学敏.中药学[M].北京：人民卫生出版社,2000：1785-1790.
[13]刘晓荣.寿胎丸治疗先兆流产100例[J].中医民间疗法.1998,10(5)：93.
[14]朱艳菊.加味寿胎丸治疗先兆流产240例[J].国医论坛.2000,15(4)：22.
[15]郑春霞.寿胎丸合助气补漏汤治疗先兆流产218例[J].河南中医.2002,22(5)：65.
[16]李兵兵,刘维立,陈立怀.寿胎丸加减治疗肾虚型先兆流产36例临床观察[J].吉
林中医药,2008,28(3)：191.
[17]朱金凤.寿胎丸加味治疗先兆流产的临床观察及实验研究[J].中西医结合杂志,1987,7(7)：407.
[18]皇新.寿胎丸加味保胎增智34例分析[J].中国误诊学杂志.2007,7(18)：4368-4369
[19]清·傅山著《傅青主男女科》[M]..北京：中国中医药出版社,1999：55.
[20]张锡纯.《医学衷中参西录》[M]..山西：山西科学技术出版社,2009：412.
[21]庞慧民,朱玉琢,高九春.杜仲对小鼠生殖细胞的遗传毒性[J].中国公共卫生.2006,22(9)：1152.
[22]明·张介宾《景岳全书》[M]..北京：人民卫生出版社,2007：174.
[23]姚荣玉,李琴,余爱丽.药物流产对再次妊娠并发症的影响[J].中华临床医药与护理.2004,10：1-2.
[24]季建媚,孙亮.探讨人工流产与不良妊娠结局的关系[J].浙江临床医学.2009,11(3)：277-278.
[25]邹燕,李幼平,吕琳,等.药物流产对再次妊娠影响的系统评价[J].中国循证医学杂志.2003,3(3)：186-194.
[26]刘超,陈光亮,王钦茂.中药妊娠毒理研究进展(综述)[J].北京中医药大学学报.1998,21(6)：37-39.
[27]覃丹丹,仇小强,张志勇,等.广西2000年出生缺陷环境致畸因素危险度评价[J].环境与职业医学.2004,21(2)：135-138.
[28]刘丹卓,尤昭玲,等.寿胎丸对SD孕鼠生殖功能及其胚胎发育的毒性研究[J].甘肃中医学院学报.2008,25(6)：6-9.
[29]尤昭玲,刘丹卓,等.寿胎丸对CHL细胞株染色体畸变影响的研究[J].湖南中医药大学学报.2008,28(3)：3-4,7.
[30]刘丹卓,尤昭玲,等.养精种玉汤对KM小鼠骨髓细胞微核率的影响[J].山西中医.2009,25(5)：52-56.
[31]许爽君,杨水清,王建萍,等.补肾益冲丸的毒理学实验研究[J].中国中医急症.2007,7：852-853.
[32]刘月凤,符达,袁慧.杜仲提取物的致突变实验研究[J].时珍国医国药.2009,20(3)：679-680.
[33]陆培信,刘冰,董皎.黄芩遗传毒性实验研究[J].白求恩医科大学学报.2001,27(4)：356-357.
[34]杨丽萍,杨幼明,杨钧.黄芩对大鼠胚胎致畸作用的观察[J].中国比较医学杂志.2003,13(3)：155-158.
[35]彭树新,李啸红.桑寄生的遗传毒理学研究[J].中国优生与遗传杂志.2008,16(12)：46-48.
[36]倪文澎,邱召娟.单味黄芪和含黄芪复方的遗传毒性检测[J].中华现代中西医杂志.2004,2(2)：161.
[1]Browning JF, Butt WR, Lynch SS,et al.Maternal plasma concentrations of P-lipotrophin, β-endorphin, andy-lipotrophin throughout pregnancy[J].Br J Obstet Gynecol.1983,90:1147.
[2]Wadhwa PD,Dunkel-SchetterC,Chicz-Denver A,et al.Prenatal paychosocial factors and then euroendocrine axis in human pregnancy[J]. Psychosom Med.1996;58:432.
[3]Nakamura H,Seto T,Nagase H,et al. Inhibitory effect of pregnancy on stressinduced immunosuppression through corticotrophin releasing hormone (CRH) and dopaminergic systems[J]. J Neuro Immunol.1997;75:1.
[4]Sandman CA,Wadhwa PD,Chicz-Demet A,et al. Maternal stress, HPA activity and fetal/infant outcome[J].Ann N Y Acad Sci,1997;814:266.
[5]Hatasaka HH,Recurrent miscarriage, epidemiologic factors, definitions and incidence[J].Clin Obstet Gynecol.1994;37:625.
[6]马红霞,尤昭玲,王若光.菟丝子总黄酮对大鼠流产模型血清P. PR、Th1/Th2细胞因子表达的影响[J].中药材.2008,31(8)：1201-1204.
[7]金志春张敦兰王旭莹周可为彭敏王晓红芦劲代莉韩少云肖丽达.药流安颗粒对早孕药流妇女血清激素PRL E2 P T β-hCG水平的影响[J].辽宁中医杂志.2007,34(8)：13-15.
[8]李予,张清学,杨冬梓,麦美琪.胚胎移植后14天单次血HCG预测妊娠结局的探讨[J].实用妇产科杂志.2005,21(8)：483-485.
[9]李明勋梁艳楠张明.孕晚期母血HCG、HPL及HCG/HPL比值异常与不良妊娠结局关系的研究[J].齐齐哈尔医学院学报.2007,28(8)：916-917.
[10]冯立娟,陆学媚.保胎灵I号治疗反复自然流产对母体免疫平衡及内分泌功能的影响[J].中国医药导报.2008,10(7)：1042-1044.
[11]丁亚军,陈意振,宋逸民,屠越坷.内啡肽在先兆流产孕妇中变化的初步观察[J].中国优生与遗传杂志.2001,9(2)57-58.
[12]Sandman CA, Wadhwa PD, Chicz DA, et al. Maternal stress, HPA activity and fetal/infant outcome[J]. Ann N Y Acad Sci.1997,814:266-280.
[13]孙斐,俞瑾.中药治疗先兆流产对血浆p-内啡肽和胎盘内分泌的影响[J].中国中西医结合杂志.1999,19(2)：87-89.
[14]Mathews PM. Enhancement of natural cytotoxicity by β-endor-phin[J] J Imunul.1983,30:1658-1662.
[15]国家中医药管理局.中华本草[M].上海；上海科学技术出版社,1996：1556-1558
[16]钟向真.自身免疫型习惯性流产的临床治疗[J].中国优生与遗传杂志.2006,14(11)：38-42.
[17]张士芬,陆启滨.抗心磷脂抗体与反复自然流产的研究进展[J].深圳中西医结合杂志.2003,13(2)：78.
[18]Meek S C et al.Auto immunity in infertile patients with endometrosis[J]. Am J Obstet Gynecol.1998,158-165.
[19]沈丽萍,金洁,程建军,等.抗精子抗体和抗子宫内膜抗体与反复自然流产关系研究[J].实用临床医学杂志.2007,13(1)：35.
[20]王越,王金龙.习惯性流产免疫学病因的研究进展[J].国外医学：妇产科分册.2005,28(6)：591-593.
[21]林其德.复发性流产免疫学诊断和治疗共识[J].生殖医学杂志.2008,17(1)：4-6.
[22]张涛,李伟莉,陈丽娟.中医药治疗免疫性流产研究进展[J].中医药临床杂志.2008,20(1)：97-99.
[23]王昕.中医治疗抗心磷脂抗体阳性习惯性流产43例分析[J].中医药学刊.2004,22(5)：945.
[24]叶利群.补肾活血法合阿司匹林治疗ACA阳性复发性流产45例[J].江西中医药.2008,39(10)：63-64.
[25]俞调忠.中药促AsAb、EmAb阳性转阴70例临床观察[J].江苏中医药.2003,24(10)：36-37.
[26]Kammerer, U, Marzusch, K, Krober, S. et al. A subset of CD56+ large granular lymphocytes in first-trimester human deciduas are proliferating cells [J]. Fertil Steril.1999,71:74-79.
[27]Coulam-CB,Goodman-C,et al.Systemic CD56+cells can predict pregnancy outcome[J].Am-J-Reprod-Immunol.1995,33(1):40-46.
[28]赵卫秀,林其德.正常妊娠早期孕妇外周血自然杀伤细胞亚群的变化[J].中华妇产科杂志.1998,33：362.
[29]李敏,高瑞珍,赵淑霞,等.自然流产患者外周血与蜕膜组自然杀伤细胞亚群数量变化的研究[J].中国优生与遗传杂志.2001,9(6)：50-53.
[30]陈巧儿,秦卫兵,杨宁,叶嘉玲.免疫治疗原因不明反复自然流产后Thl/Th2型细胞因子和NK细胞的变化[J].中国妇幼保健.2005,20(20)：2637-2639.
[31]余进胜,彭来勤,张丙忠.复发性自然流产患者NK细胞活性变化的研究[J].广州医药.2004,35(3)：35-37.
[32]王海燕,王振海.蜕膜NK细胞与自然流产[J].国外医学计划生育分册.1998,7(3)：149-152.
[33]D. Rastogi, C. Wang, C. Lendor,et al. T-helper type 2 polarization among asthmatics during and following pregnancy[J].Clin Exp Allergy.2006,36(7):892-898
[34]Kwak-Kim J,Lee S K,Gilman-Sachs A,et al,Elevated Thl/Th2 cell ratios in a pregnant woman with a history of RSA,secondary Sjogren's syndrome and rheumatoid arthritis complicated with one fetal demise of twin pregnancy [J]. Am J Reprod Immunol.2007,58(4):325-329.
[35]夏革清, 王泽华, 吴超英.Th1/Th2型细胞因子在不明原因早期自然流产绒毛和蜕膜组织中的表达[J].实用医学杂志.2009,25(17)：2852-2854.
[36]Kwak-Kim J,Lee S K,Gilman-Sachs A.Elevated Thl/Th2 cell ratios in a pregnant woman with a history of RSA,secondary Sj(o)gren's syndrome and rheumatoid arthritis complicated with one fetal demise of twin pregnancy[J].Am J Reprod Immunol.2007,58(4):325-329.
[37]De-Punzio C, Neri E, Metelli P, et al. The relationship between maternal relaxation and plasma beta-endorphin levels during parturition[J]. Psychosom Obstet ecol.1994,15(4):205-210.
[38]胡电,古航,洪新如,刘彦,金志军,王成海,曹立萍,内源性阿片肽在正常妊娠和分娩中的变化[J].第二军医大学学报.2003,24(3)：311-313.
[39]Fajardo MC, Florido J, Villaverde C, et al. Plasma levels of beta-endorphin and ACTH during labor and immediate puerperiam[J]. Eur J Obstet Gsmecol Reprod Biol.1994,55(2):105-108.
[40]孙斐,严敦清,张崇理,俞瑾.早期先兆流产妇女血浆p-内啡肽的研究[J].生殖医学杂志.1998,7(3)：141-144.
[41]丁亚军.陈意振,宋逸民.屠越坷.内啡肽在先兆流产孕妇中变化的初步观察[J].中国优生与遗传杂志.2001,9(2)：57-58.
[1]侯家玉.中药药理学[M].北京：中国中医药出版社.2002：30,31,32.
[2]骆和生,罗鼎辉,主编.免疫中药学[M].北京：北京医科大学/中国协和医科大学联合出版社,1999：87.
[3]裴小静.对促孕、保胎、催乳相关中药与子代安全性问题的思考[J].中国中药杂志.2008,33(22)：2719-2720.
[4]中の敬吾.妊娠期服用当归芍药散患者的随访调查[J].国外医学中医中药.1984,(6)：27.
[5]国凤容.寿胎丸治疗先兆流产和习惯性流产对娩出之婴幼儿的细胞遗传学研究[J].辽宁中医杂志.1984,(10)：22.
[6]张玉珍.中医药防治自然流产的追踪调查[J].新中医.1990,(4)：55-56.
[7]杨成林.先兆流产经中医药保胎小儿智能发育的调查.中国中西医结合杂志[J].1992,(3)：175.
[8]归绥琪,曹玲仙,毛秋芝,等.补肾益气清热法治疗先兆流产及对小儿的影响[J].上海中医药杂志.1995,(3)：12-13.
[9]董燕赵颖.补肾健脾中药安胎后对子代智力和体格发育的影响[Jl.新乡医学院学报.2007,24(5)：477-479.
[10]覃丹丹,仇小强,张志勇,等.广西2000年出生缺陷环境致畸因素危险度评价[J].环境与职业医学.2004,21(2)：135-138.
[11]刘丹卓,尤昭玲,等.寿胎丸对SD孕鼠生殖功能及其胚胎发育的毒性研究『J].甘肃中医学院学报.2008,25(6)：6-9.
[12]尤昭玲,刘丹卓,等.寿胎丸对CHL细胞株染色体畸变影响的研究[Jl.湖南中医药大学学报.2008,28(3)：3-4,7.
[13]刘丹卓,尤昭玲,等.养精种玉汤对KM小鼠骨髓细胞微核率的影响[J].山西中医,2009,25(5)：52-53,56.
[14]许爽君,杨水清,王建萍,等.补肾益冲丸的毒理学实验研究[J].中国中医急症,2007,7：852-853.
[15]刘月凤,符达,袁慧.杜仲提取物的致突变实验研究[J].时珍国医国药.2009,20(3)：679-680.
[16]陆培信,刘冰,董皎.黄芩遗传毒性实验研究[J].白求恩医科大学学报.2001,27(4)：356-357.
[17]杨丽萍,杨幼明,杨钧.黄芩对大鼠胚胎致畸作用的观察[J].中国比较医学杂志.2003,13(3)：155-158.
[18]彭树新,李啸红.桑寄生的遗传毒理学研究[J].中国优生与遗传杂志,2008,16(12)：46-48.
[19]倪文澎,邱召娟.单味黄芪和含黄芪复方的遗传毒性检测[J].中华现代中西医杂志.2004,2(2)：161.
[20]皇新.寿胎丸加味保胎增智34例分析[J].中国误诊学杂志.2007,7(18)：4369-4370.
[1]胡厚宣,<殷人疾病考>,《学思》[M]1934,(3)：34.
[2]刘敏如主编,《中医妇科学》[M],北京：人民卫生出版社,2006：260,281.
[3]汉·张仲景《金匮要略》[M]北京：人民卫生出版社,2009：77.
[4]晋·王叔和《脉经》[M]上海：科学技术出版社,2005：67.
[5]隋·巢元方《诸病源候论》[M]北京：人民卫生出版社,1959：482.
[6]明·李梃《医学入门》[M]北京：人民卫生出版社,2006：863.
[7]明·武之望《济阴纲目》[M]北京：人民卫生出版社,2006：32.
[8]宋·陈自明《妇人大全良方》[M]北京：人民卫生出版社,2005：114.
[9]清·叶桂《叶氏女科证治》[M]上海：锦章书局,1955：15.
[10]清·吴谦《医宗金鉴》[M]北京：人民卫生出版社,2005：65.
[11]唐·孙思邈《备急千金要方》[M]北京：人民卫生出版社,2005：27.
[12]宋·齐仲甫.女科百问.见：《精选中医妇科名著》[M]北京：中国中医药出版社，1996：498.
[13]明·王纶《明医杂著》[M]北京：中国中医药出版社,2009：90.
[14]明·万全《万氏家传广嗣纪要》[M]湖北：湖北科学技术出版社,1986：69.
[15]明·张介宾《景岳全书》[M]北京：人民卫生出版社,2007：817.
[16]元·朱震亨《格致余论》[M]北京：人民卫生出版社,2007：76.
[17]清·王清任《医林改错》[M]北京：人民卫生出版社,2007：35.
[18]清·陈梦雷《古今图书集成医部全录第九册妇科》[M]北京：人民卫生出版社,1995：56.
[19]唐·昝殷《经效产宝》[M]北京：人民卫生出版社,2007：18.
[20]唐·王焘《外台秘要》[M]北京：人民卫生出版社,2000：34.
[21]宋·朱端章《卫生家宝产科备要》[M]上海：上海古籍出版社,2004：37.
[22]元·朱震亨《丹溪心法》[M]北京：人民卫生出版社,2007：295.
[23]明·王肯堂《证治准绳》[M]北京：人民卫生出版社,2001：67.
[24]清·傅山《傅青主男女科》[M].北京：中国中医药出版社,1999：43.
[25]张锡纯《医学衷中参西录》[M].山西：山西科学技术出版社,2009：89.
[26]胥受天主编.《中医妇科学》[M].上海：上海科学技术出版社,1980：5.
[27]哈荔田.《哈荔田妇科医案医话选》[M].天津：天津科技出版社,1982：17.
[28]罗元恺.《百科全书·中医妇科学》[M].上海：上海科学技术出版社,1983：328.
[29]宋光济.安胎六法在妇科临床的应用[J].上海中医药杂志.1989,(3)：9.
[30]马宝璋.试论安胎必补肾兼调养气血[J].中医药学报.1988,(1)：34.
[31]王自平.妊娠早期出血辨证施治[J].中原医刊.1987,(3)：3.
[32]周咏芳.胎漏证治之体会[J].湖南中医杂志.1986,(3)：28-29.
[33]宓伟毅.加味二至九治疗先兆流产131例[J].浙江中医杂志.1998,3(4)：161.
[34]张莹,李玛建,涂序珉.养血安胎颗粒对反复自然流产患者非孕期NK及Ts细胞活性的影响[J].中国优生与遗传杂志.2006,14(6)：55-66.
[35]蔡丽慧,赵卫.中西医结合治疗免疫性反复性早期流产56例分析[J].中医药学刊.2002,20(4)：39.
[36]应震红,章以森.中西医结合治疗ABO血型不合疗效观察[J].实用中医药杂志.2004,20(6)：315.
[37]莫蕙,郭慧红.免疫性不孕(AsAb阳性)中医病机探讨[J].南京中医药大学学 报.1998,19(12)：8.
[38]罗颂平,张玉珍.免疫性自然流产与免疫性不孕的临床与实验研究[J].中医杂志.1997：38(6)：351.
[39]王云凤,陆启斌.补肾活血法治疗抗心磷脂抗体阳性免疫性流产的研究[J].甘肃中医.2008,21(1)：8-9.
[40]林苑琪,林茂彦,林进雄.论保胎之补脾益肾与活血化瘀[J].中华中医药学刊.2007,25(3)：546-547.
[41]张玉珍.罗元恺教授经验方“滋肾育胎丸”临床总结(附150例疗效分析)[J].新中医杂志[.1983,(3)：11.
[42]阎乐法,刘锐.调免1号治疗免疫异常增高型反复自然流产临床研究[J].山东中医杂志.2005,24(12)：717-718.
[43]景苏玉,归绥祺.“保胎1冲剂”提高反复自然流产患者免疫功能的临床观察[J].上海中医药杂志.2002,(9)：23-24.
[44]吴宁,张桂荣.中药复方优生宁对先兆流产病人免疫功能的影响[J].哈尔滨商业大学学报.2002,18(1)：43-44.
[45]孟安琪,王岩.抗自然流产颗粒治疗抗心磷脂抗体导致流产33例观察[J].中医药学刊.2005,23(12)：2211-2213.
[46]卫爱武,李颖.中西医结合治疗抗磷脂抗体致反复性流产30例[J].四川中医.2004,22(9)：57-59.
[47]郝琳,孙立峰,孙立芳.育孕保胎胶囊治疗先兆流产210例临床观察[J].河北中医.2005,27(5)：339-340.
[48]张丽蓉,习惯性流产针灸治疗558例.世界针灸学会联合会成立暨第一届世界针灸学术大会论文摘要选编[C]；1987年
[49]梁静霞,谢感共.灵龟八法及针刺治疗先兆流产60例疗效观察[J].深圳中西医结合杂志.2005,15(2)：106.
[50]朱惠云.中药内服外敷治疗先兆流产260例[J].广西中医药.2001,24(4)：43.
[51]赵伟.脐疗法配合胎元饮治疗先兆流产30例[J].河南中医.2007,27(9)：51.
[52]肖俊芳.穴位注射治疗习惯性流产22例[J].中国针灸.2000,8：60.
[53]梁兆松.先兆流产多因虚药粥保胎功效奇[J].药膳食疗.2005,4：7.
[54]刘显磊,罗颂平,梁国珍,等.助孕3号方及拆方防治肾虚黄体抑制动物流产模型的实验研究[J].生殖与避孕.2003,23(1)：17-22.
[55]孙斐,俞瑾.中药治疗先兆流产对血浆β-内啡肽和胎盘内分泌的影响[J].中国中西医结合杂志.1999,19(2)：87-89.
[56]吴宁,贾长茹,单丽艳.优生宁对先兆流产病人内分泌功能的影响[J].中医药学报.2000,28(2)：25-26.
[57]张剑峰,归绥琪.中药治疗对反复自然流产患者抗CD抗原封闭效率和血清泌乳素及孕酮的影响[J].中国中西医结合杂志.2004,24(4)：303-305.
[58]赵薇,陈霞.滋肾柔肝法对先兆流产患者体内性激素的影响[J].辽宁中医杂志.2002,29(1)：38-39.
[59]韩慧,罗颂平.助孕3号方对大鼠子宫收缩活动的影响[J].第八届全国中医妇科学学术交流大会论文集.2000,219-222.
[60]崔晓萍,胎儿安冲剂治疗先兆流产的止血作用实验研究[J].陕西中医学院学报.2003,26(3)：38-40.
[61]李应全,徐红岩,张斌,等.固胎液的药效学研究[J].山东医药工 业.2000,19(5)：43-44.
[62]水正,陈华英,柴阿园.少腹逐汤治疗先兆流产68例观察[J].吉林中医药.2003,23(4)：19.
[63]曹立幸,韩冰,李同玺,等.益气养血、固肾安胎法对肾虚流产免疫因素影响的实验研究[J].天津中医.2001,18(5)：35.
[64]周英,罗颂平,许丽绵,等.助孕3号方对肾虚黄体抑制流产大鼠母胎界面Th1/Th2细胞因子的影响研究.现代中西医结合杂志[J].2008,17(1)：12-14.
[65]蒋立辉,归绥琪,李昆明,等.中药对溴隐亭致流产大鼠保胎机理的实验研究[J].中国免疫学杂志.2002,18(10)：105.
[66]顾文平.安胎养血方治疗先兆流产68例[J].浙江中医学院学报.2006,30(1)：32.
[67]乐杰.妇产科学[M].第七版,北京：人民卫生出版社,2008：89.
[68]王少花,王霞.妇产科合理用药[M].第一版,北京：人民卫生出本社,2004：46.
[69]俞霭峰.妇产科内分泌学下册[M].上海科技教育出版社,1985：145.
[70]汪宏波,占海英,李红发.黄体功能不全患者着床期子宫内蒙雌孕激素受体的表达及超微结构改变[J].中国妇幼保健.2004,19(6)：44-46.
[71]周传清,郭慧兰,尚学瑞.绒毛膜促性腺激素治疗黄体功能不足所致流产[J].中国实用医药.2007,2(25)：45.
[72]曹泽毅.中华妇产科学[M].北京：人民卫生出版社.2005：599.
[73]Sbracia M, Mastrone M, Scarpellini F, et al. Influence of histocompatibility antige ns in recurrent spontaneous abortions and on their reproductive perforfamce[J]. Am J Repord Immunol.1996,35:85-92.
[74]Kishore R, Agarwal S, Halder A, et al. HLA sharing, anti-paternal cytotoxic antib odies and MLR blocking factors in women with recurrent spontaneous abortion[J]. J Obstet Gynecol Res.1996,22(2):177-183.
[75]林其德.复发性流产免疫学诊断和治疗共识[J],生殖医学杂志,2008,17(1)：4-6.
[76]袁耀警,盛丹青.妇产科学新理论与新技术[J],上海科技教育出版社.1996：568.
[77]Yao J, Milliez J, Netter A, et al. J Gynecol Obstet Biol Repord, 1997,26(3):304-308.
[78]张世训,宋永红,吕红娟.免疫疗法在原因不明习惯性流产中的应用[J].临床输血与检验.2004,6(3)：196-203.
[79]吴晓黎,陈新玲,徐明华.原因不明的习惯性流产患者的免疫治疗[J].中华现代临床医学杂志.2005,3(20)：17-21.
[80]韩宝生,孙琳杰,吴剑华.反复自然流产的免疫因素分析探讨[J].中国优生与遗传杂志.2003,(4)：193-196.
[81]沈小红,周婕.免疫因素与反复自然流产的关系[J].中华医学实践杂志.2004,3(12)：308.
[82]钟向真.自身免疫型习惯性流产的临床治疗[J].中国优生与遗传杂志.2006,(11)：38-42.
[83]张士芬,陆启滨.抗磷脂抗体与反复自然流产的研究进展[J].深圳中西医结合杂志.2003,13(2)：78.
[84]Meek S C et al.Autoimmunityi ninfertile patients with endometrosis[J].Am J Obstet Gynecol.1998;158-165.
[85]沈丽萍,金洁,程建军,等.抗精子抗体和抗子宫内膜抗体与反复自然流产关系研究[J].实用临床医学杂志.2007,13(1)：35.
[86]王越,王金龙.习惯性流产免疫学病因的研究进展[J].国外医学：妇产科分册.2006,28(6)：591-593.
[87]李大金.生殖免疫学[M],十一五规划教材,上海：复旦大学出版社.2008：145.
[88]何亚平,岳利民,张金虎,等.抗生殖抗体与女性不孕的关系[J].现代预防医学.2000,27(1)：69-71.
[89]郭辉,王庆荣,张朝霞.反复流产的免疫学研究进展『J].中国优生与遗传杂志.2008,16(2)：127-128.
[90]Matalon ST, Blank M, Levy Y.et al. The pathogenic role of anti-thyroglobulin antibody on pregnancy:evidence from an active immunization model in mice[J]. Hum Reprod.2003,18(5):1094-1099.
[91]邱丽华.原因不明复发性流产与Thl／Th2型细胞因子[J].国外医学·计划生育分册.2000,19(1)：20-23.
[92]D. Rastogi, C. Wang, C. Lendor,et al. T-helper type 2 polarization among asthmatics during and following pregnancy[J].Clin Exp Allergy.2006,36(7):892-898.
[93]罗丽兰.不孕与不育[M],北京：人民卫生出版社.2007：315.
[94]王淑贞主编.妇产科理论与实践[M]第2版,上海：上海科学技术出版社.1991：847
[95]刘素青,王爱玲,王帆.黄体酮联合HCG治疗不明原因习惯性流产98例[J].陕西医学杂志.2004,33(2)：164-165.
[96]小林凉一 他产妇人の科[M].世界1990；42：49.
[97]Ellen J.Immunization as therapy for recurrent spontaneous abortion:A review and meta-analysis[J].Obstet Gynecol.1993,82(5):854-859.
[98]Daya S,Gunby J,Clark DA. Intravenous immunoglobulin therapy for recurrent spontaneous abortion:a meta-analysis[J]. American Journal of Reproductive Immunology.1998(2):69-76.
[99]Katz I, Fisch B, Amit S, et al. Cutaneous graft-versus-host-like reaction after paternal lymphocyte immunizationfor prevention of recurrent abortion[J]. Fertil steril.1992,57(4):927-929.
[100]钟向真.自身免疫型习惯性流产的临床治疗[J].中国优生与遗传杂志.2006,14(11)：38-42.
[101]张士芬,陆启滨.抗磷脂抗体与反复自然流产的研究进展[J].深圳中西医结合杂志.2003(2)：78.
[102]卢春芬.心理干预在先兆流产治疗中的作用[J].现代中西医结合杂志.2007,16(12)：1693-1694.
[103]卢春芬.音乐疗法在先兆流产治疗中的疗效观察[J].解放军护理杂志.2007,24(4)：96.
[104]匡丽君,匡继林.中西结合治疗早期先兆流产临床观察[J].中华中医药学刊,2007,25(7)：1527.
[105]谢一红,胡慧娟.中西医结合孕前孕后并治复发性流产69例临床观察[J].浙江中医杂志.2008,43(8)：457-458.
[106]邓卫红,中西医结合治疗妊娠早期先兆流产100例疗效观察[J].浙江中医杂志.2009,44(2)：117-119.
[107]何志华,车盼芬.中西医结合治疗先兆流产的临床研究及对分娩结局的观察[J].2007,7(2)：32-35
[108]朱巧玲,李淑华.中西医结合治疗早期先兆流产137例[J].甘肃中医.2009,24(4)：45-46.
[109]谢一红,胡慧娟.中西医结合孕前孕后并治复发性流产69例临床观察[J].浙江中医杂志.2008,43(8)：457-458.
[110]陈萍.中西医综合治疗复发性自然流产143例分析[J].中国误诊学杂志.2008,8(22)：5422-5423.
[111]张立青.中西医结合治疗习惯性流产43例临床观察[J].甘肃中医.2009,28(2)：122-123.
[112]叶利群.补肾活血法合阿司匹林治疗ACA阳性复发性流产45例[J].江西中医药.2008,39(10)：63-64
[113]李鹤梅.中西医结合治疗ABO母儿血型不合的临床研究[J].中华临床医学研究杂志.2007,13(14)：2078-2079.
[114]王雅琴.中西医结合治疗ABO母儿血型不合习惯性流产102例[J].河北中医.2009,31(8)：1188-1190.
[115]李卫红.中西医结合治疗支原体感染反复自然流产[J].四川中医.2006,24(1)：86-87.
[116]钟学礼主编.内分泌代谢病学[M].上海：上海科学技术出版社.1984：21.
[117]Browning JF, Butt WR,Lynch SS,et al, Maternal plasma concentrations of β-lipotrophin, β-endorphin, and y-lipotrophin throughout pregnancy[J],Br J O bstet Gynecol.1983;90:1147.
[118]池芝盛编译.内分泌学基础与临床[M].北京：北京协和医院,1987：4.
[119]Terzic M,Sulvic V,Stimec B, et al. The role of beta-endorphin in pregnancy and delivery[J].Clin Exp Obstet Gynecol.1995;22:43.
[120]Browning JF, Butt WR, Lynch SS,et al.Maternal plasma concentrations of β-lipotrophin,β-endorphin,and γ-lipotrophin throughout pregnancy[J]. Br J Obstet Gynecol.1983,90:1147.
[121]Wadhwa P D,Dunkel-SchetterC,Chicz-Denver A, et al.Prenatal paychosocial factors and then euroendocrine axis in human pregnancy[J]. Psychosom Med.1996;58:432.
[122]Nakamura H,Seto T,Nagase H,et al. Inhibitory effect of pregnancy on stressinduced immunosuppression through corticotrophin releasing hormone (CRH) and dopaminergic systems[J]. J Neuro Immunol.1997;75:1.
[123]Sandman CA,Wadhwa PD,Chicz-Demet A,et al. Maternal stress, HPA activity and fetal/infant outcome[J]. Ann N Y Acad Sci.1997;814:266.
[124]Hatasaka HH,Recurrent miscarriage, epidemiologic factors, definitions and incidence[J].Clin Obstet Gynecol.1994,37:625.
[125]孙斐,严敦清,张崇礼,等,早期先兆流产妇女血浆p-内啡肽的研究[J].生殖医学杂志,1998,7(3)：141-144.
[126]丁亚军,陈意振,宋逸民.等.β-内啡肽在先兆流产孕妇中变化的初步观察[J].中国优生与遗传杂志.2001；9(2)：57.
[127]Neale DM,Mor GThe role of Fas mediated apoptosis in preeclampsi[J]a.J Perinat Med.2005,33(6):471-477.
[128]Shimoya K,Matsuzaki N,Taniguchi T,et al.Human placenta consti-Tutively produces mterleulin-8 during pregnancy and enhances its production in intrauterine infaction[J].Biol Reprod.1992,47:220.
[129]Raghupathy R,Makhseed M,Azizieh F,et al.Maternal Th1- and Th2-type reactivity to placental antigens in normal humanpregnancy and unexplained recurrent spontaneous abortions[J].Cell Immunol.1999,196(2):122-130.
[130]Makhseed M,Raghupathy R,Azizieh F,et al.Mitogen-in-duced cytokine responses of maternal peripheral blood lymphocytesindicate a differential Th-type bias in normal pregnancy and pregnancy failure[J].Am J Reprod Immunol.1999,42 (5):273-281.
[131]董琳,朱晓勇,杜美蓉,等.环孢霉素A对小鼠自然流产模型外周CD4+CD25+T细胞及妊娠结局的影响[J].现代免疫学.2006,26(2)：113-115.
[132]邢福祺,孔令红.肿瘤坏死因子α与γ干扰素诱导人绒毛膜滋养层细胞凋亡的研究[J].中华妇产科杂志.1999,34(8)：476-478.
[133]Tangri S, Wegmann TG, Lin H, et al. Maternal anti-placentalrea ctivity in natural immunologically-mediated fetal resorptions[J] J Immunol.1994,152:4903.
[134]Polgar K, Patrick W Yacono BS, et al. Immune interferon gamma inhibits translational m -obility of aplasma membrane protein in preimplantation stage mouse embryos:A T-helper 1 m -echanism for immunologic reproductive failture[J]. Am J Obstet Gynecol.1996,174:282.
[135]CupurdijaK,Azzola D,HainzU,et al.Macrophages ofhuman first trimester decidua express markers associated to alternative activation[J].Am J Reprod Immunol.2004,51 (2):117-220.
[136]Chaout QBafaile N L,Dubanchet S,et al.Reprod immunol 2003:reassessing the Thl/Th2 paradigm[J]. Immunol Lett,2004,92:207-214.
[137]Szekeres-Bartho J,Wegmann TG.A progesterone-dependent immuno modulatory protein alters the Thl/Th2 balance[J]. J Reprod Immunol.1996,31(1-2):81-95.
[138]Saito S, Umekage H, Nishikawa K, et al. Interlenkin 4(IL-4) block the IL-2 induced i -ncrease in natural killer activity and DNA synthesis of decidual CD16-CD56brightNK cells by in habiting expression of the IL-2 receptor α、βand γ[J].Cell Immunol.1996,170:71.
[139]Duelos AJ, Haddad EK, Baines MG. Presence of activated macrophages in a murine model of early embryo loss[J].Am J Reprod Immunol.1995,33:354.
[140]Haddad EK, Duclos AJ, Lapp WS, et al. Early embryoloss is associated with the prior expression of macrophage activation markers in the decidua[J]. J Immunol.1997,158:4886.
[141]Hill JA,Polgar k,Anderson DJ,et al.T-heiper Ⅰ-typer imunty totropho Mast in woman with recurrent spontaneous abortion[J] JAMA.1997,273 (24):1933.
[142]Paradisi R,Porcu E,Venturoli S,et al.Maternal serum levels of pro-inflammatory cytokines in missed and threatened abortion[J].Am J Reprod Immunol. 2003,50(4):302.
[143]孙琪,王秀华.IL-10对人滋养层细胞中HLA-GmRNA表达和HCG分泌的影响[J].实用妇产科杂志.2004,20(1)：46.
[144]刘慧萍,尤昭玲,雷磊,等.寿胎丸对反复自然流产模型小鼠母胎界面TNF-a mRNA和IL-4mRNA表达的影响[J].中医药导报.2008,14(10)：4-7.
[145]Paulesu L,Romagnoli R,Fortino V,et al.Distribution of type-1 interferon-receptors in human first trimester and term placental tissues and on isolated trophoblast cells[J].Am J Reprod Immunol.1997,37 (6):443-448.
[146]Wilson R,Jenkins C,Miller H,et al.Abnormal cytokinelevels in non-pregnant women with a history of recurrent mis-carriage.Eur J Obstet Gynecol Reprod Biol[J].2004,115(1):51-54.
[147]Hill JA 3rd,Choi BC.Immunodystrophism:evidence for a novel alloimmune hypothesis for recurrent pregnancy loss involving Th2-type immunity to trophoblast[J].Semin Reprod Med.2000,18(4):401-405.
[148]Loke YW,K ing A.Immunology of human placental implantation:clinical implications of our current understanding. Molecular Medicine Today[J].1997,3(4):153-159.
[149]King A,Luke YW, Chaoat G.NK cells and reproduction. Immunology Today[J]. 1997,18(2):64-66.
[150]Koopman LA, Kopcow HD, Rybalov B, Boyson JE, Orange JS, Schatz F,Masch R Lockwood CJ, Schachter AD,Park PJ, Strominger JL.Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential[J]. Journal of Experimental Medicine 2003,198(8):1201-1212.
[151]Kwak JYH, Beaman KD,Gilman-Sachs A, Ruiz JE,Schewitz D,Beer AE.Up-regulatede xpressiono fC D56+,C D56+/CD56,and CD19+ cells in peripheral blood lymphocytes in pregnant women with recurrent pregnancy losses[J].Am J Reprod Immunol.1995,34:93-99.
[152]Higucbi K,Aoki K,Kimbara T,Hosoi N,Yamamoto T,Okada H.Suppression of natural killer cell activity by monocytes following immunotherapy for recurrent spontaneous aborters[J].Am J Reprod Immunol.1995,33:221-227.
[153]Chao KH,Yang YS,Ho HN,Chen SU,Chen HF, Dai HJ, Huang SC, Gill TJ 3rd. Decidual natural killer cytotoxicity decreased in normal pregnancy but not in anembryonic pregnancy and recurrents pontaneous abortion[J].American Jounral of Reproductive Immunology.1995,34(5):274-80.
[154]Aoki K, Kajiura S, Matsumoto Y, et al, Preconceptional natural-killer-cell activity as a predictor of miscarriage[J]. Lancet.1995,345:1340-1342.
[155]Emmer PM,Veerboek M,Nelen WL, Steegers EA, Joosten I. Natural killer cell reactivity and HLA-G in recurrent spontaneous abortion[J]. Transplant Proc.1999,31:1838-1840.
[156]Yamada H,Morikawa M,Kato EH,Sbimada S,Kobashi QMinakami H. Preconceptional natural-killer-cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype[J]. Am J Reprod Immunol.2003,50(4):351-354.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |